{"title": "Clinical Laboratory Improvement Program (CLIP)", "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_0", "group_s": "DoDI 6440.02 CH 1.pdf_0", "doc_type": "DoDI", "doc_num": "6440.02", "type": "document", "init_date": "NA", "change_date": "NA", "entities": ["OSD", "President", "Military Department", "CMS", "VA", "DHA", "Office of the Inspector General of the Department of Defense", "Navy", "Chief Management Officer", "Army", "Air Force", "USD\u00a9", "Assistant Secretary of Defense for Health Affairs", "DoD", "FDA", "Defense Health Agency", "Office of the Chairman of the Joint Chiefs of Staff and the Joint Staff", "HHS", "Combatant Commands", "United States", "ASD", "Department of Defense", "Laboratory", "Under Secretary of Defense for Personnel and Readiness", "Food and Drug Administration", "Office"], "author": "NA", "signature": "NA", "subject": "NA", "classification": "NA", "par_count_i": 87, "text": "Department of Defense INSTRUCTION NUMBER 6440.02 May 29 2014 Incorporating Change 1 Effective May 7 2020 USDPR SUBJECT Clinical Laboratory Improvement Program CLIP References See Enclosure 1 1. PURPOSE. This instruction a. Reissues DoD Instruction DoDI 6440.2 Reference a in accordance with the authority in DoD Directive 5124.02 Reference b and pursuant to the Memorandum of Understanding between the Department of Defense and the Department of Health and Human Services HHS Reference c Public Law 100578 Reference d and part 493 of Title 42 Code of Federal Regulations Reference e to establish policy assign responsibilities and prescribe standards and procedures to implement and administer the CLIP within the DoD. b. Establishes the Center for Clinical Laboratory Medicine CCLM formerly known as the Clinical Laboratory Improvement Program Office under the Defense Health Agency DHA. CCLM has the primary responsibility to develop Clinical Laboratory Improvement Amendments CLIA comparable regulations and administer the CLIP in accordance with Reference c. 2. APPLICABILITY. This instruction applies to the OSD the Military Departments the Office of the Chairman of the Joint Chiefs of Staff and the Joint Staff the Combatant Commands the Office of the Inspector General of the Department of Defense the Defense Agencies the DoD Field Activities and all other organizational entities within the DoD referred to collectively in this instruction as the DoD Components. 3. POLICY a. In accordance with Reference c CLIA comparable regulations will incorporate to the maximum extent possible the regulations issued by HHS pursuant to Reference e. These may be modified only as may be required to meet unique aspects of DoD missions training and preparations during peace contingency and wartime operations which precludes exact compliance with CLIA. DoDI 6440.02 May 29 2014 Change 1 05072020 2 b. In accordance with this instruction and Reference c the DoD will ensure the quality and reliability of laboratory testing at facilities conducting testing on materials derived from the human body for the purpose of providing information for the diagnosis prevention or treatment of any disease or impairment of or the assessment of the health of human beings. 4. RESPONSIBILITIES. See Enclosure 2. 5. PROCEDURES. See Enclosure 3. 6. RELEASABILITY. Cleared for public release. This instruction is available on the Directives Division Website at httpswww.esd.whs.milDD. 7. SUMMARY OF CHANGE 1. The change to this issuance updates references and removes expiration language in accordance with current Chief Management Officer of the Department of Defense direction. 8. EFFECTIVE DATE. This instruction is effective May 29 2014. Enclosures 1. References 2. Responsibilities 3. Procedures Glossary DoDI 6440.02 May 29 2014 Change 1 05072020 CONTENTS 3 TABLE OF CONTENTS ENCLOSURE 1 REFERENCES ...................................................................................................4 ENCLOSURE 2 RESPONSIBILITIES .........................................................................................5 ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS ASDHA ..............5 DIRECTOR DHA .....................................................................................................................5 SECRETARIES OF THE MILITARY DEPARTMENTS........................................................5 ENCLOSURE 3 PROCEDURES ..................................................................................................7 DHA ...........................................................................................................................................7 CCLM .......................................................................................................................................7 MILITARY DEPARTMENTS ..................................................................................................8 GLOSSARY ..................................................................................................................................11 PART I ABBREVIATIONS AND ACRONYMS ................................................................11 PART II DEFINITIONS ........................................................................................................11 DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 1 4 ENCLOSURE 1 REFERENCES a DoD Instruction 6440.2 DoD Clinical Laboratory Improvement Program April 20 1994 hereby cancelled b DoD Directive 5124.02 Under Secretary of Defense for Personnel and Readiness USDPR June 23 2008 c Memorandum of Understanding between the Department of Defense and the Department of Health and Human Services on the Clinical Laboratory Improvement Amendments of 1988 CLIA 1988 January 14 2009 d Public Law 100578 Clinical Laboratory Improvement Amendments of 1988 October 31 1988 e Part 493 of Title 42 Code of Federal Regulations f Chapter 55 of Title 10 United States Code g DoD Manual 6440.02 Clinical Laboratory Improvement Program CLIP Manual May 29 2014 DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 2 5 ENCLOSURE 2 RESPONSIBILITIES 1. ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS ASDHA. Under the authority direction and control of the Under Secretary of Defense for Personnel and Readiness the ASDHA a. Establishes DoD procedures and supporting guidance. Exercises authority oversight and responsibility for implementation of CLIAcomparable regulations within DoD pursuant to Reference c and in accordance with References d and e and Chapter 55 of Title 10 United States Code Reference f. b. Establishes the CCLM in the DHA. 2. DIRECTOR DHA. Under the authority direction and control of the ASDHA a. Executes those responsibilities and functions pertaining to the daytoday operations of the CCLM and CLIP as described in Enclosure 3 of this instruction. b. Appoints the Director CCLM. This position should rotate among the three O6level CCLM Military Department Directors. 2. SECRETARIES OF THE MILITARY DEPARTMENTS. The Secretaries of the Military Departments a. Implement CLIP requirements within their respective Department\u2019s Active and Reserve Components and facilities under their supervision to include oversight inspections proficiency testing personnel standards and training in laboratories performing testing on human specimens as defined under laboratory in the Glossary of this instruction. b. In accordance with DoD Manual 6440.02 Reference g follow CLIP procedures for corrective action on laboratory facilities whose proficiency testing or performance criteria fall outside the standards of CLIP policy. c. In accordance with Reference g implement the standards and procedures governing the operation management and oversight of clinical laboratory assets assigned to operational forces. Except where operational constraints preclude compliance the standards governing clinical laboratory assets assigned to operational forces will incorporate the CLIP policy to the maximum extent possible without impeding operational requirements. d. Recommend changes and revisions to CLIP standards to CCLM. DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 2 6 e. Oversee Surgeon General laboratory commander and laboratory medical director implementation of the procedures in Enclosure 3 of this instruction. DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 3 7 ENCLOSURE 3 PROCEDURES 1. DHA. The DHA a. Provides administrative and operational management and support to CCLM including the budget personnel information facilities and other resources required to support the missions and function of the CCLM. The Director DHA at least annually reports CCLM activities to the Assistant Secretary of Defense for Health Affairs ASDHA. b. The Director DHA secures adequate funding for the CCLM. Funding will be within the Defense Health Program DHP incorporated with the Military Health System DHP submission during the Budget Estimation Submission President\u2019s Budget and Program Objective Memorandum. 2. CCLM. The Director CCLM a. Plans organizes and leads the technical and management operations of CCLM and applies resources to shortterm and longterm goals. Coordinates complex and future administration and business strategy programs with DoD senior leaders and headquarters staff. Interacts with the Joint Staff other government agencies and laboratory customers of the Military Departments driving programmatic and budgetary initiatives. b. Coordinates the daytoday activities of the CCLM in accordance with the policies established by the OASDHA and the plans programs standards and procedures established by the DoD and the Military Departments. c. Develops and establishes the minimum standards and procedures and CLIA comparable regulations to be used by the Military Departments to implement References b c and d. d. Serves as the primary laboratory representative with Centers for Medicare  Medicaid Services CMS Food and Drug Administration FDA and other federal and civilian agencies. e. Working in coordination with the DoDDepartment of Veterans Affairs VA Laboratory Joint Working Group LJWG provides unified leadership to guide and influence OASDHA policy and decision making on DoD clinical and anatomic pathology operations. f. Leads standardization and consolidation efforts across the DoD and when or where appropriate with the VA to improve utilization quality and customer support while focusing on cost effective business practices. These coordinated efforts may include but are not limited to the following DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 3 8 1 Establish interService networks and referral lab services to coordinate recapture and direct implementation of standardized or consolidated military laboratory services or initiatives in the most costeffective manner. 2 Identify and make recommendations to the Military Departments concerning duplicative services to ensure costeffective utilization of laboratory resources in the directcare and purchasedcare sectors. 3 Develop processes and structures guiding laboratory medicine related decisions and policies as appropriate. 4 Collaborate with the Military Departments to develop DoD laboratory medicine costing funding and manning mechanisms as appropriate. 5 Research and recommend clinical and anatomic laboratory information management systems recommend advances to and implement stateoftheart technology and establish full system interoperability for laboratory data transfer. 6 Coordinate interService efforts for equipment standardization and contract management. 7 Working in coordination with the Executive Secretary of the DoD Laboratory Network DLN and within the governance rules of the DLN will Establish support and expand as appropriate for biodefense the continental United States and outside the continental United States Laboratory Response Network in conjunction with the Centers for Disease Control FDA VA and other federal agencies. 8 Establish support and expand test systems and processes as appropriate for readiness and force health protection in both ingarrison medical treatment facilities and in deployed military treatment facilities. 3. MILITARY DEPARTMENTS a. The Surgeons General of the Military Departments 1 Appoint laboratory officers in the grade of O6 to serve as clinical laboratory consultant or specialty leader to their respective Surgeon General and as their Military Department\u2019s Director at CCLM. The same individual may serve in both capacities for a Military Department. 2 Assign three medical laboratory technicians one from each Department  Air Force Army and Navy in the grade of E7 or above serving as CLIP program managers for their respective Military Department. All CCLM members carry out CCLM assignments as their primary duty. These are priority fill positions and require an interview by the respective CCLM Military Department Director. DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 3 9 3 Assign additional staff to include one Air Force Biomedical Laboratory Officer in the grade of O4 serving as the Deputy Director CCLM one Army Clinical Laboratory Officer in the grade 0304 possessing an advanced Information Technology degree to serve as the Laboratory Informatics Program Manager one Navy Advanced Laboratory Technician in the grade of E5 or above serving as the Assistant Program Manager of CLIP. These are priority fill positions and require an interview by the respective CCLM Military Department Director. b. Commanders of laboratories performing testing on materials derived from the human body for the purpose of diagnosis or treatment will ensure compliance with CLIA comparable regulations as defined by CCLM and ensure CLIP registration of all medical laboratories within their command as applicable. c. Laboratory medical directors have primary oversight and responsibility for ensuring compliance with all regulations and guidance described in References b c and d and other applicable accrediting agency requirements and CCLM standards and procedures. d. The Military Department Directors CCLM 1 Provide executive oversight of the CLIP program for their respective Military Department. Monitor regulatory and statutory changes to public law and recommend appropriate changes to DoD standards. Maintain contact with regulatory organizations or other agencies for the provision of inspection accreditation and proficiency testing services required for DoD laboratories. 2 Monitor proficiency testing and accreditation agency inspection results and overall CLIP compliance for their respective service laboratories. When deemed necessary initiate or recommend enforcement procedures. Review and validate corrective action plans. Provide information on performance or deficiencies to the respective Surgeons General when action is required for resolution. 3 Issue laboratory certification documents and certify all appropriate clinical laboratory testing sites within the DoD. 4 As the OASDHA designee a Impose sanctions or other corrective actions deemed appropriate for CLIP certified laboratories with repetitive failures of CMSapproved proficiency failures or other non compliance with CLIP policy and CLIA comparable regulations as defined by CCLM. b Revoke the CLIP certification of laboratories whose actions significantly endanger patient care. c Reinstate the CLIP certification for laboratories that have successfully completed corrective actions. DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 3 10 5 Interact with their respective Military Department\u2019s Surgeon General on matters relating to References c d e and f. 6 Provide to the ASDHA Director DHA and Military Department Surgeons General a listing of clinical laboratories of the DoD Components to which suspension limitation or revocation of CLIP certificates have been imposed. 7 Provide information on clinical laboratory issues and regulatory compliance to registered sites via newsletters seminars and workshops as appropriate. Respond to regulatory and accreditation compliance questions from registered sites. 8 Provide consultation and impact analysis for laboratory policy issues for the ASDHA Director DHA and Military Department Surgeons General. 9 Prepare reports for laboratory consulting activities for the ASDHA Director DHA and Military Department Surgeons General. 10 Respond to complaints relative to laboratory services from federal State or DoD beneficiaries and provides consultation or inspection of sites where appropriate. 11 Assist the Director CCLM with the duties outlined in paragraphs 2a through 2f of this enclosure. e. CLIP Program Managers and Assistant Program Managers 1 Serve as primary liaison for their respective Military Department\u2019s laboratories on matters pertaining to the CLIP. 2 In accordance with Reference d assist in executive oversight of the CLIP program for their respective Military Department. Maintain contact with regulatory organizations or other agencies for the provision of inspection accreditation and proficiency testing services required for DoD laboratories. 3 Monitor proficiency testing and accreditation agency inspection results and overall CLIP compliance for their respective service laboratories. When necessary initiate or recommend enforcement procedures. Review and validate corrective action plans. Provide information on performance or deficiencies to the respective Military Department\u2019s Director or the CCLM Deputy Director when action is required for resolution. 4 Prepare laboratory certification documents for all appropriate clinical laboratory testing sites within their Military Department. 5 Maintain CLIP database and prepare reports of laboratory activities for their respective Military Department\u2019s Director or the CCLM Deputy Director. DoDI 6440.02 May 29 2014 Change 1 05072020 GLOSSARY 11 GLOSSARY PART I. ABBREVIATIONS AND ACRONYMS ASDHA Assistant Secretary of Defense for Health Affairs CCLM Center for Clinical Laboratory Medicine CLIA Clinical Laboratory Improvement Amendments of 1988 CLIP Clinical Laboratory Improvement Program CMS Centers for Medicare  Medicaid Services DHA Defense Health Agency DHP Defense Health Program DLN DoD Laboratory Network DoDI DoD instruction FDA Food and Drug Administration HHS Department of Health and Human Services LJWG Laboratory Joint Working Group OASDHA Office of the Assistant Secretary of Defense for Health Affairs VA Department of Veterans Affairs PART II. DEFINITIONS These terms and their definitions are for the purposes of this instruction. CLIA comparable regulations. Regulations and instructions for the DoD Components based on the CLIA regulations issued by the HHS. CLIA comparable regulations are similar to but not necessarily identical to HHS CLIA regulations modified only as may be required to meet unique aspects of DoD missions training and preparations during peace contingency and wartime operations which preclude compliance with CLIA. CLIP. Body of rules and regulations establishing the minimum standards for clinical laboratory operations within the DoD developed by CCLM with the approval of OASDHA and implemented by DoD Components. laboratory. A facility for the biological microbiological serological chemical immunohematological hematological biophysical cytological pathological or other examination of materials derived from the human body for the purpose of providing information for the diagnosis prevention or treatment of any disease or impairment of or the assessment of the health of human beings. These examinations also include procedures to determine measure DoDI 6440.02 May 29 2014 Change 1 05072020 GLOSSARY 12 or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens or both or only serving as a mailing service and not performing testing are not considered laboratories. LJWG. An organization that provides unified leadership to guide and influence OASDHA policy and decision making on DoD clinical and anatomic laboratory operations. Leads standardization and consolidation efforts across the DoD and when or where appropriate with the VA to improve utilization quality and customer support while focusing on cost effective business practices. ", "page_count": 12, "pages": [{"type": "page", "p_text": "Department of Defense INSTRUCTION NUMBER 6440.02 May 29 2014 Incorporating Change 1 Effective May 7 2020 USDPR SUBJECT Clinical Laboratory Improvement Program CLIP References See Enclosure 1 1. PURPOSE. This instruction a. Reissues DoD Instruction DoDI 6440.2 Reference a in accordance with the authority in DoD Directive 5124.02 Reference b and pursuant to the Memorandum of Understanding between the Department of Defense and the Department of Health and Human Services HHS Reference c Public Law 100578 Reference d and part 493 of Title 42 Code of Federal Regulations Reference e to establish policy assign responsibilities and prescribe standards and procedures to implement and administer the CLIP within the DoD. b. Establishes the Center for Clinical Laboratory Medicine CCLM formerly known as the Clinical Laboratory Improvement Program Office under the Defense Health Agency DHA. CCLM has the primary responsibility to develop Clinical Laboratory Improvement Amendments CLIA comparable regulations and administer the CLIP in accordance with Reference c. 2. APPLICABILITY. This instruction applies to the OSD the Military Departments the Office of the Chairman of the Joint Chiefs of Staff and the Joint Staff the Combatant Commands the Office of the Inspector General of the Department of Defense the Defense Agencies the DoD Field Activities and all other organizational entities within the DoD referred to collectively in this instruction as the DoD Components. 3. POLICY a. In accordance with Reference c CLIA comparable regulations will incorporate to the maximum extent possible the regulations issued by HHS pursuant to Reference e. These may be modified only as may be required to meet unique aspects of DoD missions training and preparations during peace contingency and wartime operations which precludes exact compliance with CLIA. ", "p_raw_text": "Department of Defense \nINSTRUCTION \nNUMBER 6440.02 \nMay 29, 2014 \nIncorporating Change 1, Effective May 7, 2020 \nUSD(P&R) \nSUBJECT: Clinical Laboratory Improvement Program (CLIP) \nReferences: See Enclosure 1 \n1. PURPOSE.  This instruction:\na. Reissues DoD Instruction (DoDI) 6440.2 (Reference (a)), in accordance with the authority\nin DoD Directive 5124.02 (Reference (b)) and pursuant to the Memorandum of Understanding \nbetween the Department of Defense and the Department of Health and Human Services (HHS) \n(Reference (c)), Public Law 100-578 (Reference (d)), and part 493 of Title 42, Code of Federal \nRegulations (Reference (e)), to establish policy, assign responsibilities, and prescribe standards \nand procedures to implement and administer the CLIP within the DoD. \nb. Establishes the Center for Clinical Laboratory Medicine (CCLM), formerly known as the\nClinical Laboratory Improvement Program Office, under the Defense Health Agency (DHA).  \nCCLM has the primary responsibility to develop Clinical Laboratory Improvement Amendments \n(CLIA) comparable regulations and administer the CLIP in accordance with Reference (c). \n2. APPLICABILITY.  This instruction applies to the OSD, the Military Departments, the Office\nof the Chairman of the Joint Chiefs of Staff and the Joint Staff, the Combatant Commands, the\nOffice of the Inspector General of the Department of Defense, the Defense Agencies, the DoD\nField Activities, and all other organizational entities within the DoD (referred to collectively in\nthis instruction as the \u201cDoD Components\u201d).\n3. POLICY\na. In accordance with Reference (c), CLIA comparable regulations will incorporate, to the\nmaximum extent possible, the regulations issued by HHS pursuant to Reference (e).  These may \nbe modified only as may be required to meet unique aspects of DoD missions, training, and \npreparations during peace, contingency, and wartime operations which precludes exact \ncompliance with CLIA. \n", "p_page": 0, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_0"}, {"type": "page", "p_text": "DoDI 6440.02 May 29 2014 Change 1 05072020 2 b. In accordance with this instruction and Reference c the DoD will ensure the quality and reliability of laboratory testing at facilities conducting testing on materials derived from the human body for the purpose of providing information for the diagnosis prevention or treatment of any disease or impairment of or the assessment of the health of human beings. 4. RESPONSIBILITIES. See Enclosure 2. 5. PROCEDURES. See Enclosure 3. 6. RELEASABILITY. Cleared for public release. This instruction is available on the Directives Division Website at httpswww.esd.whs.milDD. 7. SUMMARY OF CHANGE 1. The change to this issuance updates references and removes expiration language in accordance with current Chief Management Officer of the Department of Defense direction. 8. EFFECTIVE DATE. This instruction is effective May 29 2014. Enclosures 1. References 2. Responsibilities 3. Procedures Glossary ", "p_raw_text": "DoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n2 \nb. In accordance with this instruction and Reference (c), the DoD will ensure the quality and\nreliability of laboratory testing at facilities conducting testing on materials derived from the \nhuman body for the purpose of providing information for the diagnosis, prevention, or treatment \nof any disease or impairment of, or the assessment of the health of, human beings. \n4. RESPONSIBILITIES.  See Enclosure 2.\n5. PROCEDURES.  See Enclosure 3.\n6. RELEASABILITY.  Cleared for public release.  This instruction is available on the\nDirectives Division Website at https://www.esd.whs.mil/DD/.\n7. SUMMARY OF CHANGE 1.  The change to this issuance updates references and removes\nexpiration language in accordance with current Chief Management Officer of the Department of\nDefense direction.\n8. EFFECTIVE DATE.  This instruction is effective May 29, 2014.\nEnclosures \n1. References\n2. Responsibilities\n3. Procedures\nGlossary \n", "p_page": 1, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_1"}, {"type": "page", "p_text": "DoDI 6440.02 May 29 2014 Change 1 05072020 CONTENTS 3 TABLE OF CONTENTS ENCLOSURE 1 REFERENCES ...................................................................................................4 ENCLOSURE 2 RESPONSIBILITIES .........................................................................................5 ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS ASDHA ..............5 DIRECTOR DHA .....................................................................................................................5 SECRETARIES OF THE MILITARY DEPARTMENTS........................................................5 ENCLOSURE 3 PROCEDURES ..................................................................................................7 DHA ...........................................................................................................................................7 CCLM .......................................................................................................................................7 MILITARY DEPARTMENTS ..................................................................................................8 GLOSSARY ..................................................................................................................................11 PART I ABBREVIATIONS AND ACRONYMS ................................................................11 PART II DEFINITIONS ........................................................................................................11 ", "p_raw_text": "DoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nCONTENTS \n3 \nTABLE OF CONTENTS \nENCLOSURE 1:  REFERENCES ...................................................................................................4 \nENCLOSURE 2:  RESPONSIBILITIES .........................................................................................5 \nASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS (ASD(HA)) ..............5 \nDIRECTOR, DHA .....................................................................................................................5 \nSECRETARIES OF THE MILITARY DEPARTMENTS........................................................5 \nENCLOSURE 3:  PROCEDURES ..................................................................................................7 \nDHA ...........................................................................................................................................7 \nCCLM  .......................................................................................................................................7 \nMILITARY DEPARTMENTS ..................................................................................................8 \nGLOSSARY ..................................................................................................................................11 \nPART I:  ABBREVIATIONS AND ACRONYMS ................................................................11 \nPART II:  DEFINITIONS ........................................................................................................11 \n", "p_page": 2, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_2"}, {"type": "page", "p_text": "DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 1 4 ENCLOSURE 1 REFERENCES a DoD Instruction 6440.2 DoD Clinical Laboratory Improvement Program April 20 1994 hereby cancelled b DoD Directive 5124.02 Under Secretary of Defense for Personnel and Readiness USDPR June 23 2008 c Memorandum of Understanding between the Department of Defense and the Department of Health and Human Services on the Clinical Laboratory Improvement Amendments of 1988 CLIA 1988 January 14 2009 d Public Law 100578 Clinical Laboratory Improvement Amendments of 1988 October 31 1988 e Part 493 of Title 42 Code of Federal Regulations f Chapter 55 of Title 10 United States Code g DoD Manual 6440.02 Clinical Laboratory Improvement Program CLIP Manual May 29 2014 ", "p_raw_text": "DoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 1 \n4 \nENCLOSURE 1 \nREFERENCES \n(a)\nDoD Instruction 6440.2, \u201cDoD Clinical Laboratory Improvement Program,\u201d April 20, 1994\n(hereby cancelled)\n(b)\nDoD Directive 5124.02, \u201cUnder Secretary of Defense for Personnel and Readiness\n(USD(P&R)),\u201d June 23, 2008\n(c)\nMemorandum of Understanding between the Department of Defense and the Department of\nHealth and Human Services on the Clinical Laboratory Improvement Amendments of 1988\n(CLIA 1988), January 14, 2009\n(d)\nPublic Law 100-578, \u201cClinical Laboratory Improvement Amendments of 1988,\u201d\nOctober 31, 1988\n(e)\nPart 493 of Title 42, Code of Federal Regulations\n(f)\nChapter 55 of Title 10, United States Code\n(g)\nDoD Manual 6440.02, \u201cClinical Laboratory Improvement Program (CLIP) Manual,\u201d\nMay 29, 2014\n", "p_page": 3, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_3"}, {"type": "page", "p_text": "DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 2 5 ENCLOSURE 2 RESPONSIBILITIES 1. ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS ASDHA. Under the authority direction and control of the Under Secretary of Defense for Personnel and Readiness the ASDHA a. Establishes DoD procedures and supporting guidance. Exercises authority oversight and responsibility for implementation of CLIAcomparable regulations within DoD pursuant to Reference c and in accordance with References d and e and Chapter 55 of Title 10 United States Code Reference f. b. Establishes the CCLM in the DHA. 2. DIRECTOR DHA. Under the authority direction and control of the ASDHA a. Executes those responsibilities and functions pertaining to the daytoday operations of the CCLM and CLIP as described in Enclosure 3 of this instruction. b. Appoints the Director CCLM. This position should rotate among the three O6level CCLM Military Department Directors. 2. SECRETARIES OF THE MILITARY DEPARTMENTS. The Secretaries of the Military Departments a. Implement CLIP requirements within their respective Department\u2019s Active and Reserve Components and facilities under their supervision to include oversight inspections proficiency testing personnel standards and training in laboratories performing testing on human specimens as defined under laboratory in the Glossary of this instruction. b. In accordance with DoD Manual 6440.02 Reference g follow CLIP procedures for corrective action on laboratory facilities whose proficiency testing or performance criteria fall outside the standards of CLIP policy. c. In accordance with Reference g implement the standards and procedures governing the operation management and oversight of clinical laboratory assets assigned to operational forces. Except where operational constraints preclude compliance the standards governing clinical laboratory assets assigned to operational forces will incorporate the CLIP policy to the maximum extent possible without impeding operational requirements. d. Recommend changes and revisions to CLIP standards to CCLM. ", "p_raw_text": "DoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 2 \n5 \nENCLOSURE 2 \nRESPONSIBILITIES \n1. ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS (ASD(HA)).  Under\nthe authority, direction, and control of the Under Secretary of Defense for Personnel and\nReadiness, the ASD(HA):\na. Establishes DoD procedures and supporting guidance.  Exercises authority, oversight, and\nresponsibility for implementation of CLIA-comparable regulations within DoD pursuant to \nReference (c) and in accordance with References (d) and (e), and Chapter 55 of Title 10, United \nStates Code (Reference (f)). \nb. Establishes the CCLM in the DHA.\n2. DIRECTOR, DHA. Under the authority, direction, and control of the ASD(HA):\na. Executes those responsibilities and functions pertaining to the day-to-day operations of the\nCCLM and CLIP as described in Enclosure 3 of this instruction. \nb. Appoints the Director, CCLM.  This position should rotate among the three O-6-level\nCCLM Military Department Directors. \n2. SECRETARIES OF THE MILITARY DEPARTMENTS.  The Secretaries of the Military\nDepartments:\na. Implement CLIP requirements within their respective Department\u2019s Active and Reserve\nComponents and facilities under their supervision to include oversight, inspections, proficiency \ntesting, personnel standards, and training in laboratories performing testing on human specimens \nas defined under \u201claboratory\u201d in the Glossary of this instruction. \nb. In accordance with DoD Manual 6440.02 (Reference (g)), follow CLIP procedures for \ncorrective action on laboratory facilities whose proficiency testing or performance criteria fall \noutside the standards of CLIP policy. \nc. In accordance with Reference (g), implement the standards and procedures governing the \noperation, management, and oversight of clinical laboratory assets assigned to operational forces.  \nExcept where operational constraints preclude compliance, the standards governing clinical \nlaboratory assets assigned to operational forces will incorporate the CLIP policy to the maximum \nextent possible without impeding operational requirements. \nd. Recommend changes and revisions to CLIP standards to CCLM.\n", "p_page": 4, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_4"}, {"type": "page", "p_text": "DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 2 6 e. Oversee Surgeon General laboratory commander and laboratory medical director implementation of the procedures in Enclosure 3 of this instruction. ", "p_raw_text": "DoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 2 \n \n6 \ne.  Oversee Surgeon General, laboratory commander, and laboratory medical director \nimplementation of the procedures in Enclosure 3 of this instruction.  \n", "p_page": 5, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_5"}, {"type": "page", "p_text": "DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 3 7 ENCLOSURE 3 PROCEDURES 1. DHA. The DHA a. Provides administrative and operational management and support to CCLM including the budget personnel information facilities and other resources required to support the missions and function of the CCLM. The Director DHA at least annually reports CCLM activities to the Assistant Secretary of Defense for Health Affairs ASDHA. b. The Director DHA secures adequate funding for the CCLM. Funding will be within the Defense Health Program DHP incorporated with the Military Health System DHP submission during the Budget Estimation Submission President\u2019s Budget and Program Objective Memorandum. 2. CCLM. The Director CCLM a. Plans organizes and leads the technical and management operations of CCLM and applies resources to shortterm and longterm goals. Coordinates complex and future administration and business strategy programs with DoD senior leaders and headquarters staff. Interacts with the Joint Staff other government agencies and laboratory customers of the Military Departments driving programmatic and budgetary initiatives. b. Coordinates the daytoday activities of the CCLM in accordance with the policies established by the OASDHA and the plans programs standards and procedures established by the DoD and the Military Departments. c. Develops and establishes the minimum standards and procedures and CLIA comparable regulations to be used by the Military Departments to implement References b c and d. d. Serves as the primary laboratory representative with Centers for Medicare  Medicaid Services CMS Food and Drug Administration FDA and other federal and civilian agencies. e. Working in coordination with the DoDDepartment of Veterans Affairs VA Laboratory Joint Working Group LJWG provides unified leadership to guide and influence OASDHA policy and decision making on DoD clinical and anatomic pathology operations. f. Leads standardization and consolidation efforts across the DoD and when or where appropriate with the VA to improve utilization quality and customer support while focusing on cost effective business practices. These coordinated efforts may include but are not limited to the following ", "p_raw_text": "DoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 3 \n7 \nENCLOSURE 3 \n \nPROCEDURES \n \n \n1.  DHA.  The DHA:   \n \n \na.  Provides administrative and operational management and support to CCLM, including the \nbudget, personnel, information, facilities, and other resources required to support the missions \nand function of the CCLM.  The Director, DHA, at least annually reports CCLM activities to the \nAssistant Secretary of Defense for Health Affairs (ASD(HA)). \n \n \nb.  The Director, DHA, secures adequate funding for the CCLM.  Funding will be within the \nDefense Health Program (DHP), incorporated with the Military Health System DHP submission \nduring the Budget Estimation Submission, President\u2019s Budget, and Program Objective \nMemorandum. \n \n \n2.  CCLM.  The Director, CCLM:  \n \na.  Plans, organizes, and leads the technical and management operations of CCLM and \napplies resources to short-term and long-term goals.  Coordinates complex and future \nadministration and business strategy programs with DoD senior leaders and headquarters staff.  \nInteracts with the Joint Staff, other government agencies and laboratory customers of the \nMilitary Departments driving programmatic and budgetary initiatives.   \n \nb.  Coordinates the day-to-day activities of the CCLM, in accordance with the policies \nestablished by the OASD(HA), and the plans, programs, standards, and procedures established \nby the DoD and the Military Departments. \n \nc.  Develops and establishes the minimum standards and procedures, and CLIA comparable \nregulations to be used by the Military Departments to implement References (b), (c), and (d). \n \nd.  Serves as the primary laboratory representative with Centers for Medicare & Medicaid \nServices (CMS), Food and Drug Administration (FDA), and other federal and civilian agencies. \n \ne.  Working in coordination with the DoD-Department of Veterans Affairs (VA) Laboratory \nJoint Working Group (LJWG), provides unified leadership to guide and influence OASD(HA) \npolicy and decision making on DoD clinical and anatomic pathology operations. \n \nf.  Leads standardization and consolidation efforts across the DoD, and when or where \nappropriate, with the VA; to improve utilization, quality, and customer support while focusing on \ncost effective business practices.  These coordinated efforts may include, but are not limited to, \nthe following: \n \n", "p_page": 6, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_6"}, {"type": "page", "p_text": "DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 3 8 1 Establish interService networks and referral lab services to coordinate recapture and direct implementation of standardized or consolidated military laboratory services or initiatives in the most costeffective manner. 2 Identify and make recommendations to the Military Departments concerning duplicative services to ensure costeffective utilization of laboratory resources in the directcare and purchasedcare sectors. 3 Develop processes and structures guiding laboratory medicine related decisions and policies as appropriate. 4 Collaborate with the Military Departments to develop DoD laboratory medicine costing funding and manning mechanisms as appropriate. 5 Research and recommend clinical and anatomic laboratory information management systems recommend advances to and implement stateoftheart technology and establish full system interoperability for laboratory data transfer. 6 Coordinate interService efforts for equipment standardization and contract management. 7 Working in coordination with the Executive Secretary of the DoD Laboratory Network DLN and within the governance rules of the DLN will Establish support and expand as appropriate for biodefense the continental United States and outside the continental United States Laboratory Response Network in conjunction with the Centers for Disease Control FDA VA and other federal agencies. 8 Establish support and expand test systems and processes as appropriate for readiness and force health protection in both ingarrison medical treatment facilities and in deployed military treatment facilities. 3. MILITARY DEPARTMENTS a. The Surgeons General of the Military Departments 1 Appoint laboratory officers in the grade of O6 to serve as clinical laboratory consultant or specialty leader to their respective Surgeon General and as their Military Department\u2019s Director at CCLM. The same individual may serve in both capacities for a Military Department. 2 Assign three medical laboratory technicians one from each Department  Air Force Army and Navy in the grade of E7 or above serving as CLIP program managers for their respective Military Department. All CCLM members carry out CCLM assignments as their primary duty. These are priority fill positions and require an interview by the respective CCLM Military Department Director. ", "p_raw_text": "DoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 3 \n8 \n \n \n(1)  Establish inter-Service networks and referral lab services to coordinate, recapture, \nand direct implementation of standardized or consolidated military laboratory services or \ninitiatives in the most cost-effective manner. \n \n \n \n(2)  Identify and make recommendations to the Military Departments concerning \nduplicative services to ensure cost-effective utilization of laboratory resources in the direct-care \nand purchased-care sectors. \n \n \n \n(3)  Develop processes and structures guiding laboratory medicine related decisions and \npolicies as appropriate. \n \n \n \n(4)  Collaborate with the Military Departments to develop DoD laboratory medicine \ncosting, funding, and manning mechanisms as appropriate. \n \n \n \n(5)  Research and recommend clinical and anatomic laboratory information management \nsystems, recommend advances to and implement state-of-the-art technology, and establish full \nsystem interoperability for laboratory data transfer. \n \n \n \n(6)  Coordinate inter-Service efforts for equipment standardization and contract \nmanagement. \n \n \n \n(7)  Working in coordination with the Executive Secretary of the DoD Laboratory \nNetwork (DLN), and within the governance rules of the DLN, will:  Establish, support, and \nexpand, as appropriate for bio-defense, the continental United States and outside the continental \nUnited States Laboratory Response Network in conjunction with the Centers for Disease \nControl, FDA, VA, and other federal agencies. \n \n \n \n(8)  Establish, support, and expand test systems and processes, as appropriate, for \nreadiness and force health protection in both in-garrison medical treatment facilities and in \ndeployed military treatment facilities. \n \n \n3.  MILITARY DEPARTMENTS \n \na.  The Surgeons General of the Military Departments: \n \n \n(1)  Appoint laboratory officers in the grade of O-6 to serve as clinical laboratory \nconsultant or specialty leader to their respective Surgeon General and as their Military \nDepartment\u2019s Director at CCLM.  The same individual may serve in both capacities for a \nMilitary Department. \n \n \n \n(2)  Assign three medical laboratory technicians (one from each Department - Air Force, \nArmy, and Navy) in the grade of E-7 or above, serving as CLIP program managers for their \nrespective Military Department.  All CCLM members carry out CCLM assignments as their \nprimary duty.  These are priority fill positions and require an interview by the respective CCLM \nMilitary Department Director. \n", "p_page": 7, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_7"}, {"type": "page", "p_text": "DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 3 9 3 Assign additional staff to include one Air Force Biomedical Laboratory Officer in the grade of O4 serving as the Deputy Director CCLM one Army Clinical Laboratory Officer in the grade 0304 possessing an advanced Information Technology degree to serve as the Laboratory Informatics Program Manager one Navy Advanced Laboratory Technician in the grade of E5 or above serving as the Assistant Program Manager of CLIP. These are priority fill positions and require an interview by the respective CCLM Military Department Director. b. Commanders of laboratories performing testing on materials derived from the human body for the purpose of diagnosis or treatment will ensure compliance with CLIA comparable regulations as defined by CCLM and ensure CLIP registration of all medical laboratories within their command as applicable. c. Laboratory medical directors have primary oversight and responsibility for ensuring compliance with all regulations and guidance described in References b c and d and other applicable accrediting agency requirements and CCLM standards and procedures. d. The Military Department Directors CCLM 1 Provide executive oversight of the CLIP program for their respective Military Department. Monitor regulatory and statutory changes to public law and recommend appropriate changes to DoD standards. Maintain contact with regulatory organizations or other agencies for the provision of inspection accreditation and proficiency testing services required for DoD laboratories. 2 Monitor proficiency testing and accreditation agency inspection results and overall CLIP compliance for their respective service laboratories. When deemed necessary initiate or recommend enforcement procedures. Review and validate corrective action plans. Provide information on performance or deficiencies to the respective Surgeons General when action is required for resolution. 3 Issue laboratory certification documents and certify all appropriate clinical laboratory testing sites within the DoD. 4 As the OASDHA designee a Impose sanctions or other corrective actions deemed appropriate for CLIP certified laboratories with repetitive failures of CMSapproved proficiency failures or other non compliance with CLIP policy and CLIA comparable regulations as defined by CCLM. b Revoke the CLIP certification of laboratories whose actions significantly endanger patient care. c Reinstate the CLIP certification for laboratories that have successfully completed corrective actions. ", "p_raw_text": "DoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 3 \n9 \n \n \n \n(3)  Assign additional staff to include:  one Air Force Biomedical Laboratory Officer, in \nthe grade of O-4 serving as the Deputy Director, CCLM; one Army Clinical Laboratory Officer \nin the grade 0-3/0-4, possessing an advanced Information Technology degree to serve as the \nLaboratory Informatics Program Manager; one Navy Advanced Laboratory Technician in the \ngrade of E-5 or above serving as the Assistant Program Manager of CLIP.  These are priority fill \npositions and require an interview by the respective CCLM Military Department Director. \n \nb.  Commanders of laboratories performing testing on materials derived from the human \nbody for the purpose of diagnosis or treatment will ensure compliance with CLIA comparable \nregulations as defined by CCLM and ensure CLIP registration of all medical laboratories within \ntheir command as applicable. \n \nc.  Laboratory medical directors have primary oversight and responsibility for ensuring \ncompliance with all regulations and guidance described in References (b), (c), and (d) and other \napplicable accrediting agency requirements and CCLM standards and procedures. \n \nd.  The Military Department Directors, CCLM: \n \n(1)  Provide executive oversight of the CLIP program for their respective Military \nDepartment.  Monitor regulatory and statutory changes to public law and recommend appropriate \nchanges to DoD standards.  Maintain contact with regulatory organizations or other agencies for \nthe provision of inspection, accreditation, and proficiency testing services required for DoD \nlaboratories. \n \n(2)  Monitor proficiency testing and accreditation agency inspection results, and overall \nCLIP compliance for their respective service laboratories.  When deemed necessary, initiate or \nrecommend enforcement procedures.  Review and validate corrective action plans.  Provide \ninformation on performance or deficiencies to the respective Surgeons General when action is \nrequired for resolution.   \n \n(3)  Issue laboratory certification documents, and certify all appropriate clinical \nlaboratory testing sites within the DoD. \n \n(4)  As the OASD(HA) designee: \n \n(a)  Impose sanctions or other corrective actions deemed appropriate for CLIP \ncertified laboratories with repetitive failures of CMS-approved proficiency failures or other non-\ncompliance with CLIP policy and CLIA comparable regulations as defined by CCLM.   \n \n(b)  Revoke the CLIP certification of laboratories whose actions significantly \nendanger patient care. \n \n(c)  Reinstate the CLIP certification for laboratories that have successfully completed \ncorrective actions.  \n \n", "p_page": 8, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_8"}, {"type": "page", "p_text": "DoDI 6440.02 May 29 2014 Change 1 05072020 ENCLOSURE 3 10 5 Interact with their respective Military Department\u2019s Surgeon General on matters relating to References c d e and f. 6 Provide to the ASDHA Director DHA and Military Department Surgeons General a listing of clinical laboratories of the DoD Components to which suspension limitation or revocation of CLIP certificates have been imposed. 7 Provide information on clinical laboratory issues and regulatory compliance to registered sites via newsletters seminars and workshops as appropriate. Respond to regulatory and accreditation compliance questions from registered sites. 8 Provide consultation and impact analysis for laboratory policy issues for the ASDHA Director DHA and Military Department Surgeons General. 9 Prepare reports for laboratory consulting activities for the ASDHA Director DHA and Military Department Surgeons General. 10 Respond to complaints relative to laboratory services from federal State or DoD beneficiaries and provides consultation or inspection of sites where appropriate. 11 Assist the Director CCLM with the duties outlined in paragraphs 2a through 2f of this enclosure. e. CLIP Program Managers and Assistant Program Managers 1 Serve as primary liaison for their respective Military Department\u2019s laboratories on matters pertaining to the CLIP. 2 In accordance with Reference d assist in executive oversight of the CLIP program for their respective Military Department. Maintain contact with regulatory organizations or other agencies for the provision of inspection accreditation and proficiency testing services required for DoD laboratories. 3 Monitor proficiency testing and accreditation agency inspection results and overall CLIP compliance for their respective service laboratories. When necessary initiate or recommend enforcement procedures. Review and validate corrective action plans. Provide information on performance or deficiencies to the respective Military Department\u2019s Director or the CCLM Deputy Director when action is required for resolution. 4 Prepare laboratory certification documents for all appropriate clinical laboratory testing sites within their Military Department. 5 Maintain CLIP database and prepare reports of laboratory activities for their respective Military Department\u2019s Director or the CCLM Deputy Director. ", "p_raw_text": "DoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 3 \n10 \n(5)  Interact with their respective Military Department\u2019s Surgeon General on matters \nrelating to References (c), (d), (e), and (f). \n \n(6)  Provide to the ASD(HA), Director DHA and Military Department Surgeons General, \na listing of clinical laboratories of the DoD Components to which suspension, limitation, or \nrevocation of CLIP certificates have been imposed. \n \n(7)  Provide information on clinical laboratory issues and regulatory compliance to \nregistered sites via newsletters, seminars, and workshops as appropriate.  Respond to regulatory \nand accreditation compliance questions from registered sites. \n \n(8)  Provide consultation and impact analysis for laboratory policy issues for the \nASD(HA), Director DHA and Military Department Surgeons General. \n \n(9)  Prepare reports for laboratory consulting activities for the ASD(HA), Director DHA \nand Military Department Surgeons General. \n \n(10)  Respond to complaints relative to laboratory services from federal, State, or DoD \nbeneficiaries and provides consultation or inspection of sites where appropriate. \n \n(11)  Assist the Director, CCLM, with the duties outlined in paragraphs 2a through 2f of \nthis enclosure. \n \ne.  CLIP Program Managers and Assistant Program Managers: \n \n(1)  Serve as primary liaison for their respective Military Department\u2019s laboratories on \nmatters pertaining to the CLIP.  \n \n(2)  In accordance with Reference (d), assist in executive oversight of the CLIP program \nfor their respective Military Department.  Maintain contact with regulatory organizations or other \nagencies for the provision of inspection, accreditation, and proficiency testing services required \nfor DoD laboratories. \n \n(3)  Monitor proficiency testing and accreditation agency inspection results and overall \nCLIP compliance for their respective service laboratories.  When necessary, initiate or \nrecommend enforcement procedures.  Review and validate corrective action plans.  Provide \ninformation on performance or deficiencies to the respective Military Department\u2019s Director or \nthe CCLM Deputy Director when action is required for resolution. \n \n(4)  Prepare laboratory certification documents for all appropriate clinical laboratory \ntesting sites within their Military Department. \n \n(5)  Maintain CLIP database and prepare reports of laboratory activities for their \nrespective Military Department\u2019s Director, or the CCLM Deputy Director. \n \n \n", "p_page": 9, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_9"}, {"type": "page", "p_text": "DoDI 6440.02 May 29 2014 Change 1 05072020 GLOSSARY 11 GLOSSARY PART I. ABBREVIATIONS AND ACRONYMS ASDHA Assistant Secretary of Defense for Health Affairs CCLM Center for Clinical Laboratory Medicine CLIA Clinical Laboratory Improvement Amendments of 1988 CLIP Clinical Laboratory Improvement Program CMS Centers for Medicare  Medicaid Services DHA Defense Health Agency DHP Defense Health Program DLN DoD Laboratory Network DoDI DoD instruction FDA Food and Drug Administration HHS Department of Health and Human Services LJWG Laboratory Joint Working Group OASDHA Office of the Assistant Secretary of Defense for Health Affairs VA Department of Veterans Affairs PART II. DEFINITIONS These terms and their definitions are for the purposes of this instruction. CLIA comparable regulations. Regulations and instructions for the DoD Components based on the CLIA regulations issued by the HHS. CLIA comparable regulations are similar to but not necessarily identical to HHS CLIA regulations modified only as may be required to meet unique aspects of DoD missions training and preparations during peace contingency and wartime operations which preclude compliance with CLIA. CLIP. Body of rules and regulations establishing the minimum standards for clinical laboratory operations within the DoD developed by CCLM with the approval of OASDHA and implemented by DoD Components. laboratory. A facility for the biological microbiological serological chemical immunohematological hematological biophysical cytological pathological or other examination of materials derived from the human body for the purpose of providing information for the diagnosis prevention or treatment of any disease or impairment of or the assessment of the health of human beings. These examinations also include procedures to determine measure ", "p_raw_text": "DoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nGLOSSARY \n11 \nGLOSSARY \n \nPART I.  ABBREVIATIONS AND ACRONYMS \n \nASD(HA) \nAssistant Secretary of Defense for Health Affairs \n \n \nCCLM \nCenter for Clinical Laboratory Medicine \nCLIA \nClinical Laboratory Improvement Amendments of 1988 \nCLIP \nClinical Laboratory Improvement Program \nCMS \nCenters for Medicare & Medicaid Services \n \nDHA \nDefense Health Agency \nDHP \nDefense Health Program \nDLN \nDoD Laboratory Network \nDoDI \nDoD instruction \n \n \nFDA \nFood and Drug Administration \n \n \nHHS \nDepartment of Health and Human Services \n \n \nLJWG \nLaboratory Joint Working Group \n \n \nOASD(HA) Office of the Assistant Secretary of Defense for Health Affairs \n \n \nVA \nDepartment of Veterans Affairs \n \n \nPART II.  DEFINITIONS \n \nThese terms and their definitions are for the purposes of this instruction. \n \nCLIA comparable regulations.  Regulations and instructions for the DoD Components based on \nthe CLIA regulations issued by the HHS.  CLIA comparable regulations are similar to, but not \nnecessarily identical to, HHS CLIA regulations, modified only as may be required to meet \nunique aspects of DoD missions, training, and preparations during peace, contingency, and \nwartime operations which preclude compliance with CLIA. \n \nCLIP.  Body of rules and regulations establishing the minimum standards for clinical laboratory \noperations within the DoD, developed by CCLM, with the approval of OASD(HA), and \nimplemented by DoD Components. \n \nlaboratory.  A facility for the biological, microbiological, serological, chemical, \nimmunohematological, hematological, biophysical, cytological, pathological, or other \nexamination of materials derived from the human body for the purpose of providing information \nfor the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of \nthe health of, human beings.  These examinations also include procedures to determine, measure, \n", "p_page": 10, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_10"}, {"type": "page", "p_text": "DoDI 6440.02 May 29 2014 Change 1 05072020 GLOSSARY 12 or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens or both or only serving as a mailing service and not performing testing are not considered laboratories. LJWG. An organization that provides unified leadership to guide and influence OASDHA policy and decision making on DoD clinical and anatomic laboratory operations. Leads standardization and consolidation efforts across the DoD and when or where appropriate with the VA to improve utilization quality and customer support while focusing on cost effective business practices. ", "p_raw_text": "DoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nGLOSSARY \n12 \nor otherwise describe the presence or absence of various substances or organisms in the body.  \nFacilities only collecting or preparing specimens (or both) or only serving as a mailing service \nand not performing testing are not considered laboratories. \n \nLJWG.  An organization that provides unified leadership to guide and influence OASD(HA) \npolicy and decision making on DoD clinical and anatomic laboratory operations.  Leads \nstandardization and consolidation efforts across the DoD; and, when or where appropriate, with \nthe VA to improve utilization, quality, and customer support while focusing on cost effective \nbusiness practices. \n", "p_page": 11, "filename": "DoDI 6440.02 CH 1.pdf", "id": "DoDI 6440.02 CH 1.pdf_11"}], "keyw_5": ["health affairs", "federal regulations", "dodi 02", "respective department", "provide information", "procedures governing", "preparing specimens", "military departments", "military department", "laboratory testing"], "paragraphs": [{"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 0, "id": "DoDI 6440.02 CH 1.pdf_0", "par_count_i": 0, "page_num": 0, "par_raw_text_t": "Department  of  Defense  \nINSTRUCTION  \nNUMBER  6440.02  \nMay  29 ,  2014  \nIncorporating  Change  1 ,  Effective  May  7 ,  2020  \nUSD ( P&R )  \nSUBJECT :  Clinical  Laboratory  Improvement  Program  ( CLIP )  \nReferences :  See  Enclosure  1  \n1 .  PURPOSE .   This  instruction : \na .  Reissues  DoD  Instruction  ( Do DI )  6440.2  ( Reference  ( a ) ) ,  in  accordance  with  the  authority \nin  DoD  Directive  5124.02  ( Reference  ( b ) )  and  pursuant  to  the  Memorandum  of  Understanding  \nbetween  the  Department  of  Defense  and  the  Department  of  Health  and  Human  Services  ( HHS )  \n( Reference  ( c ) ) ,  Public  Law  100-578  ( Reference  ( d ) ) ,  and  part  493  of  Title  42 ,  Code  of  Federal  \nRegulations  ( Reference  ( e ) ) ,  to  establish  policy ,  assign  responsibilities ,  and  prescribe  standards  \nand  procedures  to  implement  and  administer  the  CLIP  within  the  DoD .  \nb .  Establishes  the  Center  for  Clinical  Laboratory  Medicine  ( CCLM ) ,  formerly  known  as  the \nClinical  Laboratory  Improvement  Program  Office ,  under  the  Defense  Health  Agency  ( DHA ) .   \nCCLM  has  the  primary  responsibility  to  develop  Clinical  Laboratory  Improvement  Amendments  \n( CLIA )  comparable  regulations  and  administer  the  CLIP  in  accordance  with  Reference  ( c ) .  \n2 .  APPLICABILITY .   This  instruction  applies  to  the  OSD ,  the  Military  Departments ,  the  Office \nof  the  Chairman  of  the  Joint  Chiefs  of  Staff  and  the  Joint  Staff ,  the  Combatant  Commands ,  the \nOffice  of  the  Inspector  General  of  the  Department  of  Defense ,  the  Defense  Agencies ,  the  DoD \nField  Activities ,  and  all  other  organizational  entities  within  the  DoD  ( referred  to  collectively  in \nthis  instruction  as  the  \u201c DoD  Components \u201d ) . \n3 .  POLICY \na .  In  accordance  with  Reference  ( c ) ,  CLIA  comparable  regulations  will  incorporate ,  to  the \nmaximum  extent  possible ,  the  regulations  issued  by  HHS  pursuant  to  Reference  ( e ) .   These  may  \nbe  modified  only  as  may  be  required  to  meet  unique  aspects  of  DoD  missions ,  training ,  and  \npreparations  during  peace ,  contingency ,  and  wartime  operations  which  precludes  exact  \ncompliance  with  CLIA .", "entities": {"ORG_s": ["Laboratory", "OSD", "Office of the Chairman of the Joint Chiefs of Staff and the Joint Staff", "HHS", "Combatant Commands", "Department of Defense", "DoD", "DHA", "Defense Health Agency", "Office", "Office of the Inspector General of the Department of Defense"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["USD\u00a9"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 1, "id": "DoDI 6440.02 CH 1.pdf_1", "par_count_i": 0, "page_num": 1, "par_raw_text_t": "Do DI  6440.02 ,  May  29 ,  2014  \nChange  1 ,  05/07/2020  \n2  \nb .  In  accordance  with  this  instruction  and  Reference  ( c ) ,  the  DoD  will  ensure  the  quality  and \nreliability  of  laboratory  testing  at  facilities  conducting  testing  on  materials  derived  from  the  \nhuman  body  for  the  purpose  of  providing  information  for  the  diagnosis ,  prevention ,  or  treatment  \nof  any  disease  or  impairment  of ,  or  the  assessment  of  the  health  of ,  human  beings .  \n4 .  RESPONSIBILITIES .   See  Enclosure  2 . \n5 .  PROCEDURES .   See  Enclosure  3 . \n6 .  RELEASABILITY .   Cleared  for  public  release .   This  instruction  is  available  on  the \nDirectives  Division  Website  at  https://www.esd.whs.mil/DD / . \n7 .  SUMMARY  OF  CHANGE  1 .   The  change  to  this  issuance  updates  references  and  removes \nexpiration  language  in  accordance  with  current  Chief  Management  Officer  of  the  Department  of \nDefense  direction . \n8 .  EFFECTIVE  DATE .   This  instruction  is  effective  May  29 ,  2014 . \nEnclosures  \n1 .  References \n2 .  Responsibilities \n3 .  Procedures \nGlossary  \n", "entities": {"ORG_s": ["Department of Defense", "DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["Chief Management Officer"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 2, "id": "DoDI 6440.02 CH 1.pdf_2", "par_count_i": 0, "page_num": 2, "par_raw_text_t": "Do DI  6440.02 ,  May  29 ,  2014  \nChange  1 ,  05/07/2020  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 3, "id": "DoDI 6440.02 CH 1.pdf_3", "par_count_i": 1, "page_num": 2, "par_raw_text_t": "CONTENTS  \n3  \nTABLE  OF  CONTENTS  \nENCLOSURE  1 :   REFERENCES  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4  \nENCLOSURE  2 :   RESPONSIBILITIES  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5  \nASSISTANT  SECRETARY  OF  DEFENSE  FOR  HEALTH  AFFAIRS  ( ASD ( HA ) )  . . . . . . . . . . . . . . 5  \nDIRECTOR ,  DHA  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5  \nSECRETARIES  OF  THE  MILITARY  DEPARTMENTS ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..5  \nENCLOSURE  3 :   PROCEDURES  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7  \nDHA  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7  \nCCLM   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7  \nMILITARY  DEPARTMENTS  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8  \nGLOSSARY  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11  \nPART  I :   ABBREVIATIONS  AND  ACRONYMS  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11  \nPART  II :   DEFINITIONS  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11  \n", "entities": {"ORG_s": ["DHA"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["ASD", "Assistant Secretary of Defense for Health Affairs"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 4, "id": "DoDI 6440.02 CH 1.pdf_4", "par_count_i": 0, "page_num": 3, "par_raw_text_t": "Do DI  6440.02 ,  May  29 ,  2014  \nChange  1 ,  05/07/2020  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 5, "id": "DoDI 6440.02 CH 1.pdf_5", "par_count_i": 1, "page_num": 3, "par_raw_text_t": "ENCLOSURE  1  \n4  \nENCLOSURE  1  \nREFERENCES  \n( a ) \nDoD  Instruction  6440.2 ,  \u201c DoD  Clinical  Laboratory  Improvement  Program , \u201d  April  20 ,  1994 \n( hereby  cancelled ) \n( b ) \nDoD  Directive  5124.02 ,  \u201c Under  Secretary  of  Defense  for  Personnel  and  Readiness \n( USD ( P&R ) ) , \u201d  June  23 ,  2008 \n( c ) \nMemorandum  of  Understanding  between  the  Department  of  Defense  and  the  Department  of \nHealth  and  Human  Services  on  the  Clinical  Laboratory  Improvement  Amendments  of  1988 \n( CLIA  1988 ) ,  January  14 ,  2009 \n( d ) \nPublic  Law  100-578 ,  \u201c Clinical  Laboratory  Improvement  Amendments  of  1988 , \u201d \nOctober  31 ,  1988 \n( e ) \nPart  493  of  Title  42 ,  Code  of  Federal  Regulations \n( f ) \nChapter  55  of  Title  10 ,  United  States  Code \n( g ) \nDoD  Manual  6440.02 ,  \u201c Clinical  Laboratory  Improvement  Program  ( CLIP )  Manual , \u201d \nMay  29 ,  2014 \n", "entities": {"ORG_s": ["Laboratory", "Department of Defense", "United States", "DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["Under Secretary of Defense for Personnel and Readiness", "USD\u00a9"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 6, "id": "DoDI 6440.02 CH 1.pdf_6", "par_count_i": 0, "page_num": 4, "par_raw_text_t": "Do DI  6440.02 ,  May  29 ,  2014  \nChange  1 ,  05/07/2020  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 7, "id": "DoDI 6440.02 CH 1.pdf_7", "par_count_i": 1, "page_num": 4, "par_raw_text_t": "ENCLOSURE  2  \n5  \nENCLOSURE  2  \nRESPONSIBILITIES  \n1 .  ASSISTANT  SECRETARY  OF  DEFENSE  FOR  HEALTH  AFFAIRS  ( ASD ( HA ) ) .   Under \nthe  authority ,  direction ,  and  control  of  the  Under  Secretary  of  Defense  for  Personnel  and \nReadiness ,  the  ASD ( HA ) : \na .  Establishes  DoD  procedures  and  supporting  guidance .   Exercises  authority ,  oversight ,  and \nresponsibility  for  implementation  of  CLIA -comparable  regulations  within  DoD  pursuant  to  \nReference  ( c )  and  in  accordance  with  References  ( d )  and  ( e ) ,  and  Chapter  55  of  Title  10 ,  United  \nStates  Code  ( Reference  ( f ) ) .  \nb .  Establishes  the  CCLM  in  the  DHA . \n2 .  DIRECTOR ,  DHA .  Under  the  authority ,  direction ,  and  control  of  the  ASD ( HA ) : \na .  Executes  those  responsibilities  and  functions  pertaining  to  the  day -to -day  operations  of  the \nCCLM  and  CLIP  as  described  in  Enclosure  3  of  this  instruction .  \nb .  Appoints  the  Director ,  CCLM .   This  position  should  rotate  among  the  three  O -6 -level \nCCLM  Military  Department  Directors .  \n2 .  SECRETARIES  OF  THE  MILITARY  DEPARTMENTS .   The  Secretaries  of  the  Military \nDepartments : \na .  Implement  CLIP  requirements  within  their  respective  Department \u2019s  Active  and  Reserve \nComponents  and  facilities  under  their  supervision  to  include  oversight ,  inspections ,  proficiency  \ntesting ,  personnel  standards ,  and  training  in  laboratories  performing  testing  on  human  specimens  \nas  defined  under  \u201c laboratory \u201d  in  the  Glossary  of  this  instruction .  \nb .  In  accordance  with  DoD  Manual  6440.02  ( Reference  ( g ) ) ,  follow  CLIP  procedures  for  \ncorrective  action  on  laboratory  facilities  whose  proficiency  testing  or  performance  criteria  fall  \noutside  the  standards  of  CLIP  policy .  \nc .  In  accordance  with  Reference  ( g ) ,  implement  the  standards  and  procedures  governing  the  \noperation ,  management ,  and  oversight  of  clinical  laboratory  assets  assigned  to  operational  forces .   \nExcept  where  operational  constraints  preclude  compliance ,  the  standards  governing  clinical  \nlaboratory  assets  assigned  to  operational  forces  will  incorporate  the  CLIP  policy  to  the  maximum  \nextent  possible  without  impeding  operational  requirements .  \nd .  Recommend  changes  and  revisions  to  CLIP  standards  to  CCLM .", "entities": {"ORG_s": ["Military Department", "DHA", "United States", "DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["Under Secretary of Defense for Personnel and Readiness", "ASD", "Assistant Secretary of Defense for Health Affairs"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 8, "id": "DoDI 6440.02 CH 1.pdf_8", "par_count_i": 0, "page_num": 5, "par_raw_text_t": "Do DI  6440.02 ,  May  29 ,  2014  \nChange  1 ,  05/07/2020  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 9, "id": "DoDI 6440.02 CH 1.pdf_9", "par_count_i": 1, "page_num": 5, "par_raw_text_t": "ENCLOSURE  2  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 10, "id": "DoDI 6440.02 CH 1.pdf_10", "par_count_i": 2, "page_num": 5, "par_raw_text_t": "6  \ne .   Oversee  Surgeon  General ,  laboratory  commander ,  and  laboratory  medical  director  \nimplementation  of  the  procedures  in  Enclosure  3  of  this  instruction .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 11, "id": "DoDI 6440.02 CH 1.pdf_11", "par_count_i": 0, "page_num": 6, "par_raw_text_t": "Do DI  6440.02 ,  May  29 ,  2014  \nChange  1 ,  05/07/2020  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 12, "id": "DoDI 6440.02 CH 1.pdf_12", "par_count_i": 1, "page_num": 6, "par_raw_text_t": "ENCLOSURE  3  \n7  \nENCLOSURE  3  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 13, "id": "DoDI 6440.02 CH 1.pdf_13", "par_count_i": 2, "page_num": 6, "par_raw_text_t": "PROCEDURES  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 14, "id": "DoDI 6440.02 CH 1.pdf_14", "par_count_i": 3, "page_num": 6, "par_raw_text_t": "1 .   DHA .   The  DHA :    ", "entities": {"ORG_s": ["DHA"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 15, "id": "DoDI 6440.02 CH 1.pdf_15", "par_count_i": 4, "page_num": 6, "par_raw_text_t": "a .   Provides  administrative  and  operational  management  and  support  to  CCLM ,  including  the  \nbudget ,  personnel ,  information ,  facilities ,  and  other  resources  required  to  support  the  missions  \nand  function  of  the  CCLM .   The  Director ,  DHA ,  at  least  annually  reports  CCLM  activities  to  the  \nAssistant  Secretary  of  Defense  for  Health  Affairs  ( ASD ( HA ) ) .", "entities": {"ORG_s": ["DHA"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["ASD", "Assistant Secretary of Defense for Health Affairs"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 16, "id": "DoDI 6440.02 CH 1.pdf_16", "par_count_i": 5, "page_num": 6, "par_raw_text_t": "b .   The  Director ,  DHA ,  secures  adequate  funding  for  the  CCLM .   Funding  will  be  within  the  \nDefense  Health  Program  ( DHP ) ,  incorporated  with  the  Military  Health  System  DHP  submission  \nduring  the  Budget  Estimation  Submission ,  President \u2019s  Budget ,  and  Program  Objective  \nMemorandum .", "entities": {"ORG_s": ["DHA"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["President"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 17, "id": "DoDI 6440.02 CH 1.pdf_17", "par_count_i": 6, "page_num": 6, "par_raw_text_t": "2 .   CCLM .   The  Director ,  CCLM :   ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 18, "id": "DoDI 6440.02 CH 1.pdf_18", "par_count_i": 7, "page_num": 6, "par_raw_text_t": "a .   Plans ,  organizes ,  and  leads  the  technical  and  management  operations  of  CCLM  and  \napplies  resources  to  short -term  and  long -term  goals .   Coordinates  complex  and  future  \nadministration  and  business  strategy  programs  with  DoD  senior  leaders  and  headquarters  staff .   \nInteracts  with  the  Joint  Staff ,  other  government  agencies  and  laboratory  customers  of  the  \nMilitary  Departments  driving  programmatic  and  budgetary  initiatives .", "entities": {"ORG_s": ["DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 19, "id": "DoDI 6440.02 CH 1.pdf_19", "par_count_i": 8, "page_num": 6, "par_raw_text_t": "b .   Coordinates  the  day -to -day  activities  of  the  CCLM ,  in  accordance  with  the  policies  \nestablished  by  the  OASD ( HA ) ,  and  the  plans ,  programs ,  standards ,  and  procedures  established  \nby  the  DoD  and  the  Military  Departments .", "entities": {"ORG_s": ["DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 20, "id": "DoDI 6440.02 CH 1.pdf_20", "par_count_i": 9, "page_num": 6, "par_raw_text_t": "c .   Develops  and  establishes  the  minimum  standards  and  procedures ,  and  CLIA  comparable  \nregulations  to  be  used  by  the  Military  Departments  to  implement  References  ( b ) ,  ( c ) ,  and  ( d ) .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 21, "id": "DoDI 6440.02 CH 1.pdf_21", "par_count_i": 10, "page_num": 6, "par_raw_text_t": "d .   Serves  as  the  primary  laboratory  representative  with  Centers  for  Medicare  &  Medicaid  \nServices  ( CMS ) ,  Food  and  Drug  Administration  ( FDA ) ,  and  other  federal  and  civilian  agencies .", "entities": {"ORG_s": ["CMS", "Food and Drug Administration", "FDA"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 22, "id": "DoDI 6440.02 CH 1.pdf_22", "par_count_i": 11, "page_num": 6, "par_raw_text_t": "e .   Working  in  coordination  with  the  DoD -Department  of  Veterans  Affairs  ( VA )  Laboratory  \nJoint  Working  Group  ( LJWG ) ,  provides  unified  leadership  to  guide  and  influence  OASD ( HA )  \npolicy  and  decision  making  on  DoD  clinical  and  anatomic  pathology  operations .", "entities": {"ORG_s": ["Laboratory", "VA", "DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 23, "id": "DoDI 6440.02 CH 1.pdf_23", "par_count_i": 12, "page_num": 6, "par_raw_text_t": "f .   Leads  standardization  and  consolidation  efforts  across  the  DoD ,  and  when  or  where  \nappropriate ,  with  the  VA ;  to  improve  utilization ,  quality ,  and  customer  support  while  focusing  on  \ncost  effective  business  practices .   These  coordinated  efforts  may  include ,  but  are  not  limited  to ,  \nthe  following :  ", "entities": {"ORG_s": ["VA", "DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 24, "id": "DoDI 6440.02 CH 1.pdf_24", "par_count_i": 13, "page_num": 6, "par_raw_text_t": "", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 25, "id": "DoDI 6440.02 CH 1.pdf_25", "par_count_i": 0, "page_num": 7, "par_raw_text_t": "Do DI  6440.02 ,  May  29 ,  2014  \nChange  1 ,  05/07/2020  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 26, "id": "DoDI 6440.02 CH 1.pdf_26", "par_count_i": 1, "page_num": 7, "par_raw_text_t": "ENCLOSURE  3  \n8  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 27, "id": "DoDI 6440.02 CH 1.pdf_27", "par_count_i": 2, "page_num": 7, "par_raw_text_t": "( 1 )   Establish  inter -Service  networks  and  referral  lab  services  to  coordinate ,  recapture ,  \nand  direct  implementation  of  standardized  or  consolidated  military  laboratory  services  or  \ninitiatives  in  the  most  cost -effective  manner .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 28, "id": "DoDI 6440.02 CH 1.pdf_28", "par_count_i": 3, "page_num": 7, "par_raw_text_t": "( 2 )   Identify  and  make  recommendations  to  the  Military  Departments  concerning  \nduplicative  services  to  ensure  cost -effective  utilization  of  laboratory  resources  in  the  direct -care  \nand  purchased -care  sectors .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 29, "id": "DoDI 6440.02 CH 1.pdf_29", "par_count_i": 4, "page_num": 7, "par_raw_text_t": "( 3 )   Develop  processes  and  structures  guiding  laboratory  medicine  related  decisions  and  \npolicies  as  appropriate .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 30, "id": "DoDI 6440.02 CH 1.pdf_30", "par_count_i": 5, "page_num": 7, "par_raw_text_t": "( 4 )   Collaborate  with  the  Military  Departments  to  develop  DoD  laboratory  medicine  \ncosting ,  funding ,  and  manning  mechanisms  as  appropriate .", "entities": {"ORG_s": ["DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 31, "id": "DoDI 6440.02 CH 1.pdf_31", "par_count_i": 6, "page_num": 7, "par_raw_text_t": "( 5 )   Research  and  recommend  clinical  and  anatomic  laboratory  information  management  \nsystems ,  recommend  advances  to  and  implement  state -of -the -art  technology ,  and  establish  full  \nsystem  interoperability  for  laboratory  data  transfer .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 32, "id": "DoDI 6440.02 CH 1.pdf_32", "par_count_i": 7, "page_num": 7, "par_raw_text_t": "( 6 )   Coordinate  inter -Service  efforts  for  equipment  standardization  and  contract  \nmanagement .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 33, "id": "DoDI 6440.02 CH 1.pdf_33", "par_count_i": 8, "page_num": 7, "par_raw_text_t": "( 7 )   Working  in  coordination  with  the  Executive  Secretary  of  the  DoD  Laboratory  \nNetwork  ( DLN ) ,  and  within  the  governance  rules  of  the  DLN ,  will :   Establish ,  support ,  and  \nexpand ,  as  appropriate  for  bio -defense ,  the  continental  United  States  and  outside  the  continental  \nUnited  States  Laboratory  Response  Network  in  conjunction  with  the  Centers  for  Disease  \nControl ,  FDA ,  VA ,  and  other  federal  agencies .", "entities": {"ORG_s": ["Laboratory", "United States", "FDA", "DoD", "VA"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 34, "id": "DoDI 6440.02 CH 1.pdf_34", "par_count_i": 9, "page_num": 7, "par_raw_text_t": "( 8 )   Establish ,  support ,  and  expand  test  systems  and  processes ,  as  appropriate ,  for  \nreadiness  and  force  health  protection  in  both  in -garrison  medical  treatment  facilities  and  in  \ndeployed  military  treatment  facilities .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 35, "id": "DoDI 6440.02 CH 1.pdf_35", "par_count_i": 10, "page_num": 7, "par_raw_text_t": "3 .   MILITARY  DEPARTMENTS  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 36, "id": "DoDI 6440.02 CH 1.pdf_36", "par_count_i": 11, "page_num": 7, "par_raw_text_t": "a .   The  Surgeons  General  of  the  Military  Departments :  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 37, "id": "DoDI 6440.02 CH 1.pdf_37", "par_count_i": 12, "page_num": 7, "par_raw_text_t": "( 1 )   Appoint  laboratory  officers  in  the  grade  of  O -6  to  serve  as  clinical  laboratory  \nconsultant  or  specialty  leader  to  their  respective  Surgeon  General  and  as  their  Military  \nDepartment \u2019s  Director  at  CCLM .   The  same  individual  may  serve  in  both  capacities  for  a  \nMilitary  Department .", "entities": {"ORG_s": ["Military Department"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 38, "id": "DoDI 6440.02 CH 1.pdf_38", "par_count_i": 13, "page_num": 7, "par_raw_text_t": "( 2 )   Assign  three  medical  laboratory  technicians  ( one  from  each  Department  -  Air  Force ,  \nArmy ,  and  Navy )  in  the  grade  of  E -7  or  above ,  serving  as  CLIP  program  managers  for  their  \nrespective  Military  Department .   All  CCLM  members  carry  out  CCLM  assignments  as  their  \nprimary  duty .   These  are  priority  fill  positions  and  require  an  interview  by  the  respective  CCLM  \nMilitary  Department  Director .", "entities": {"ORG_s": ["Navy", "Military Department", "Army", "Air Force"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 39, "id": "DoDI 6440.02 CH 1.pdf_39", "par_count_i": 0, "page_num": 8, "par_raw_text_t": "Do DI  6440.02 ,  May  29 ,  2014  \nChange  1 ,  05/07/2020  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 40, "id": "DoDI 6440.02 CH 1.pdf_40", "par_count_i": 1, "page_num": 8, "par_raw_text_t": "ENCLOSURE  3  \n9  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 41, "id": "DoDI 6440.02 CH 1.pdf_41", "par_count_i": 2, "page_num": 8, "par_raw_text_t": "( 3 )   Assign  additional  staff  to  include :   one  Air  Force  Biomedical  Laboratory  Officer ,  in  \nthe  grade  of  O -4  serving  as  the  Deputy  Director ,  CCLM ;  one  Army  Clinical  Laboratory  Officer  \nin  the  grade  0-3/0-4 ,  possessing  an  advanced  Information  Technology  degree  to  serve  as  the  \nLaboratory  Informatics  Program  Manager ;  one  Navy  Advanced  Laboratory  Technician  in  the  \ngrade  of  E -5  or  above  serving  as  the  Assistant  Program  Manager  of  CLIP .   These  are  priority  fill  \npositions  and  require  an  interview  by  the  respective  CCLM  Military  Department  Director .", "entities": {"ORG_s": ["Laboratory", "Navy", "Military Department", "Army", "Air Force"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 42, "id": "DoDI 6440.02 CH 1.pdf_42", "par_count_i": 3, "page_num": 8, "par_raw_text_t": "b .   Commanders  of  laboratories  performing  testing  on  materials  derived  from  the  human  \nbody  for  the  purpose  of  diagnosis  or  treatment  will  ensure  compliance  with  CLIA  comparable  \nregulations  as  defined  by  CCLM  and  ensure  CLIP  registration  of  all  medical  laboratories  within  \ntheir  command  as  applicable .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 43, "id": "DoDI 6440.02 CH 1.pdf_43", "par_count_i": 4, "page_num": 8, "par_raw_text_t": "c .   Laboratory  medical  directors  have  primary  oversight  and  responsibility  for  ensuring  \ncompliance  with  all  regulations  and  guidance  described  in  References  ( b ) ,  ( c ) ,  and  ( d )  and  other  \napplicable  accrediting  agency  requirements  and  CCLM  standards  and  procedures .", "entities": {"ORG_s": ["Laboratory"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 44, "id": "DoDI 6440.02 CH 1.pdf_44", "par_count_i": 5, "page_num": 8, "par_raw_text_t": "d .   The  Military  Department  Directors ,  CCLM :  ", "entities": {"ORG_s": ["Military Department"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 45, "id": "DoDI 6440.02 CH 1.pdf_45", "par_count_i": 6, "page_num": 8, "par_raw_text_t": "( 1 )   Provide  executive  oversight  of  the  CLIP  program  for  their  respective  Military  \nDepartment .   Monitor  regulatory  and  statutory  changes  to  public  law  and  recommend  appropriate  \nchanges  to  DoD  standards .   Maintain  contact  with  regulatory  organizations  or  other  agencies  for  \nthe  provision  of  inspection ,  accreditation ,  and  proficiency  testing  services  required  for  DoD  \nlaboratories .", "entities": {"ORG_s": ["Military Department", "DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 46, "id": "DoDI 6440.02 CH 1.pdf_46", "par_count_i": 7, "page_num": 8, "par_raw_text_t": "( 2 )   Monitor  proficiency  testing  and  accreditation  agency  inspection  results ,  and  overall  \nCLIP  compliance  for  their  respective  service  laboratories .   When  deemed  necessary ,  initiate  or  \nrecommend  enforcement  procedures .   Review  and  validate  corrective  action  plans .   Provide  \ninformation  on  performance  or  deficiencies  to  the  respective  Surgeons  General  when  action  is  \nrequired  for  resolution .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 47, "id": "DoDI 6440.02 CH 1.pdf_47", "par_count_i": 8, "page_num": 8, "par_raw_text_t": "( 3 )   Issue  laboratory  certification  documents ,  and  certify  all  appropriate  clinical  \nlaboratory  testing  sites  within  the  DoD .  ", "entities": {"ORG_s": ["DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 48, "id": "DoDI 6440.02 CH 1.pdf_48", "par_count_i": 9, "page_num": 8, "par_raw_text_t": "( 4 )   As  the  OASD ( HA )  designee :  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 49, "id": "DoDI 6440.02 CH 1.pdf_49", "par_count_i": 10, "page_num": 8, "par_raw_text_t": "( a )   Impose  sanctions  or  other  corrective  actions  deemed  appropriate  for  CLIP  \ncertified  laboratories  with  repetitive  failures  of  CMS -approved  proficiency  failures  or  other  noncompliance  with  CLIP  policy  and  CLIA  comparable  regulations  as  defined  by  CCLM .", "entities": {"ORG_s": ["CMS"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 50, "id": "DoDI 6440.02 CH 1.pdf_50", "par_count_i": 11, "page_num": 8, "par_raw_text_t": "( b )   Revoke  the  CLIP  certification  of  laboratories  whose  actions  significantly  \nendanger  patient  care .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 51, "id": "DoDI 6440.02 CH 1.pdf_51", "par_count_i": 12, "page_num": 8, "par_raw_text_t": "( c )   Reinstate  the  CLIP  certification  for  laboratories  that  have  successfully  completed  \ncorrective  actions .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 52, "id": "DoDI 6440.02 CH 1.pdf_52", "par_count_i": 13, "page_num": 8, "par_raw_text_t": "", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 53, "id": "DoDI 6440.02 CH 1.pdf_53", "par_count_i": 0, "page_num": 9, "par_raw_text_t": "Do DI  6440.02 ,  May  29 ,  2014  \nChange  1 ,  05/07/2020  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 54, "id": "DoDI 6440.02 CH 1.pdf_54", "par_count_i": 1, "page_num": 9, "par_raw_text_t": "ENCLOSURE  3  \n10  \n( 5 )   Interact  with  their  respective  Military  Department \u2019s  Surgeon  General  on  matters  \nrelating  to  References  ( c ) ,  ( d ) ,  ( e ) ,  and  ( f ) .", "entities": {"ORG_s": ["Military Department"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 55, "id": "DoDI 6440.02 CH 1.pdf_55", "par_count_i": 2, "page_num": 9, "par_raw_text_t": "( 6 )   Provide  to  the  ASD ( HA ) ,  Director  DHA  and  Military  Department  Surgeons  General ,  \na  listing  of  clinical  laboratories  of  the  DoD  Components  to  which  suspension ,  limitation ,  or  \nrevocation  of  CLIP  certificates  have  been  imposed .", "entities": {"ORG_s": ["DHA", "Military Department", "DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["ASD"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 56, "id": "DoDI 6440.02 CH 1.pdf_56", "par_count_i": 3, "page_num": 9, "par_raw_text_t": "( 7 )   Provide  information  on  clinical  laboratory  issues  and  regulatory  compliance  to  \nregistered  sites  via  newsletters ,  seminars ,  and  workshops  as  appropriate .   Respond  to  regulatory  \nand  accreditation  compliance  questions  from  registered  sites .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 57, "id": "DoDI 6440.02 CH 1.pdf_57", "par_count_i": 4, "page_num": 9, "par_raw_text_t": "( 8 )   Provide  consultation  and  impact  analysis  for  laboratory  policy  issues  for  the  \nASD ( HA ) ,  Director  DHA  and  Military  Department  Surgeons  General .", "entities": {"ORG_s": ["DHA", "Military Department"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["ASD"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 58, "id": "DoDI 6440.02 CH 1.pdf_58", "par_count_i": 5, "page_num": 9, "par_raw_text_t": "( 9 )   Prepare  reports  for  laboratory  consulting  activities  for  the  ASD ( HA ) ,  Director  DHA  \nand  Military  Department  Surgeons  General .", "entities": {"ORG_s": ["DHA", "Military Department"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["ASD"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 59, "id": "DoDI 6440.02 CH 1.pdf_59", "par_count_i": 6, "page_num": 9, "par_raw_text_t": "( 10 )   Respond  to  complaints  relative  to  laboratory  services  from  federal ,  State ,  or  DoD  \nbeneficiaries  and  provides  consultation  or  inspection  of  sites  where  appropriate .", "entities": {"ORG_s": ["DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 60, "id": "DoDI 6440.02 CH 1.pdf_60", "par_count_i": 7, "page_num": 9, "par_raw_text_t": "( 11 )   Assist  the  Director ,  CCLM ,  with  the  duties  outlined  in  paragraphs  2a  through  2f  of  \nthis  enclosure .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 61, "id": "DoDI 6440.02 CH 1.pdf_61", "par_count_i": 8, "page_num": 9, "par_raw_text_t": "e .   CLIP  Program  Managers  and  Assistant  Program  Managers :  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 62, "id": "DoDI 6440.02 CH 1.pdf_62", "par_count_i": 9, "page_num": 9, "par_raw_text_t": "( 1 )   Serve  as  primary  liaison  for  their  respective  Military  Department \u2019s  laboratories  on  \nmatters  pertaining  to  the  CLIP .", "entities": {"ORG_s": ["Military Department"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 63, "id": "DoDI 6440.02 CH 1.pdf_63", "par_count_i": 10, "page_num": 9, "par_raw_text_t": "( 2 )   In  accordance  with  Reference  ( d ) ,  assist  in  executive  oversight  of  the  CLIP  program  \nfor  their  respective  Military  Department .   Maintain  contact  with  regulatory  organizations  or  other  \nagencies  for  the  provision  of  inspection ,  accreditation ,  and  proficiency  testing  services  required  \nfor  DoD  laboratories .", "entities": {"ORG_s": ["Military Department", "DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 64, "id": "DoDI 6440.02 CH 1.pdf_64", "par_count_i": 11, "page_num": 9, "par_raw_text_t": "( 3 )   Monitor  proficiency  testing  and  accreditation  agency  inspection  results  and  overall  \nCLIP  compliance  for  their  respective  service  laboratories .   When  necessary ,  initiate  or  \nrecommend  enforcement  procedures .   Review  and  validate  corrective  action  plans .   Provide  \ninformation  on  performance  or  deficiencies  to  the  respective  Military  Department \u2019s  Director  or  \nthe  CCLM  Deputy  Director  when  action  is  required  for  resolution .", "entities": {"ORG_s": ["Military Department"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 65, "id": "DoDI 6440.02 CH 1.pdf_65", "par_count_i": 12, "page_num": 9, "par_raw_text_t": "( 4 )   Prepare  laboratory  certification  documents  for  all  appropriate  clinical  laboratory  \ntesting  sites  within  their  Military  Department .", "entities": {"ORG_s": ["Military Department"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 66, "id": "DoDI 6440.02 CH 1.pdf_66", "par_count_i": 13, "page_num": 9, "par_raw_text_t": "( 5 )   Maintain  CLIP  database  and  prepare  reports  of  laboratory  activities  for  their  \nrespective  Military  Department \u2019s  Director ,  or  the  CCLM  Deputy  Director .", "entities": {"ORG_s": ["Military Department"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 67, "id": "DoDI 6440.02 CH 1.pdf_67", "par_count_i": 14, "page_num": 9, "par_raw_text_t": "", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 68, "id": "DoDI 6440.02 CH 1.pdf_68", "par_count_i": 0, "page_num": 10, "par_raw_text_t": "Do DI  6440.02 ,  May  29 ,  2014  \nChange  1 ,  05/07/2020  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 69, "id": "DoDI 6440.02 CH 1.pdf_69", "par_count_i": 1, "page_num": 10, "par_raw_text_t": "GLOSSARY  \n11  \nGLOSSARY  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 70, "id": "DoDI 6440.02 CH 1.pdf_70", "par_count_i": 2, "page_num": 10, "par_raw_text_t": "PART  I .   ABBREVIATIONS  AND  ACRONYMS  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 71, "id": "DoDI 6440.02 CH 1.pdf_71", "par_count_i": 3, "page_num": 10, "par_raw_text_t": "ASD ( HA )  \nAssistant  Secretary  of  Defense  for  Health  Affairs  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["ASD", "Assistant Secretary of Defense for Health Affairs"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 72, "id": "DoDI 6440.02 CH 1.pdf_72", "par_count_i": 4, "page_num": 10, "par_raw_text_t": "CCLM  \nCenter  for  Clinical  Laboratory  Medicine  \nCLIA  \nClinical  Laboratory  Improvement  Amendments  of  1988  \nCLIP  \nClinical  Laboratory  Improvement  Program  \nCMS  \nCenters  for  Medicare  &  Medicaid  Services  ", "entities": {"ORG_s": ["Laboratory", "CMS"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 73, "id": "DoDI 6440.02 CH 1.pdf_73", "par_count_i": 5, "page_num": 10, "par_raw_text_t": "DHA  \nDefense  Health  Agency  \nDHP  \nDefense  Health  Program  \nDLN  \nDoD  Laboratory  Network  \nDo DI  \nDoD  instruction  ", "entities": {"ORG_s": ["Laboratory", "Defense Health Agency", "DHA", "DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 74, "id": "DoDI 6440.02 CH 1.pdf_74", "par_count_i": 6, "page_num": 10, "par_raw_text_t": "FDA  \nFood  and  Drug  Administration  ", "entities": {"ORG_s": ["Food and Drug Administration", "FDA"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 75, "id": "DoDI 6440.02 CH 1.pdf_75", "par_count_i": 7, "page_num": 10, "par_raw_text_t": "HHS  \nDepartment  of  Health  and  Human  Services  ", "entities": {"ORG_s": ["HHS"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 76, "id": "DoDI 6440.02 CH 1.pdf_76", "par_count_i": 8, "page_num": 10, "par_raw_text_t": "LJWG  \nLaboratory  Joint  Working  Group  ", "entities": {"ORG_s": ["Laboratory"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 77, "id": "DoDI 6440.02 CH 1.pdf_77", "par_count_i": 9, "page_num": 10, "par_raw_text_t": "OASD ( HA )  Office  of  the  Assistant  Secretary  of  Defense  for  Health  Affairs  ", "entities": {"ORG_s": ["Office"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": ["Assistant Secretary of Defense for Health Affairs"]}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 78, "id": "DoDI 6440.02 CH 1.pdf_78", "par_count_i": 10, "page_num": 10, "par_raw_text_t": "VA  \nDepartment  of  Veterans  Affairs  ", "entities": {"ORG_s": ["VA"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 79, "id": "DoDI 6440.02 CH 1.pdf_79", "par_count_i": 11, "page_num": 10, "par_raw_text_t": "PART  II .   DEFINITIONS  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 80, "id": "DoDI 6440.02 CH 1.pdf_80", "par_count_i": 12, "page_num": 10, "par_raw_text_t": "These  terms  and  their  definitions  are  for  the  purposes  of  this  instruction .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 81, "id": "DoDI 6440.02 CH 1.pdf_81", "par_count_i": 13, "page_num": 10, "par_raw_text_t": "CLIA  comparable  regulations .   Regulations  and  instructions  for  the  DoD  Components  based  on  \nthe  CLIA  regulations  issued  by  the  HHS .   CLIA  comparable  regulations  are  similar  to ,  but  not  \nnecessarily  identical  to ,  HHS  CLIA  regulations ,  modified  only  as  may  be  required  to  meet  \nunique  aspects  of  DoD  missions ,  training ,  and  preparations  during  peace ,  contingency ,  and  \nwartime  operations  which  preclude  compliance  with  CLIA .", "entities": {"ORG_s": ["HHS", "DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 82, "id": "DoDI 6440.02 CH 1.pdf_82", "par_count_i": 14, "page_num": 10, "par_raw_text_t": "CLIP .   Body  of  rules  and  regulations  establishing  the  minimum  standards  for  clinical  laboratory  \noperations  within  the  DoD ,  developed  by  CCLM ,  with  the  approval  of  OASD ( HA ) ,  and  \nimplemented  by  DoD  Components .", "entities": {"ORG_s": ["DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 83, "id": "DoDI 6440.02 CH 1.pdf_83", "par_count_i": 15, "page_num": 10, "par_raw_text_t": "laboratory .   A  facility  for  the  biological ,  microbiological ,  serological ,  chemical ,  \nimmunohematological ,  hematological ,  biophysical ,  cytological ,  pathological ,  or  other  \nexamination  of  materials  derived  from  the  human  body  for  the  purpose  of  providing  information  \nfor  the  diagnosis ,  prevention ,  or  treatment  of  any  disease  or  impairment  of ,  or  the  assessment  of  \nthe  health  of ,  human  beings .   These  examinations  also  include  procedures  to  determine ,  measure ,  \n", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 84, "id": "DoDI 6440.02 CH 1.pdf_84", "par_count_i": 0, "page_num": 11, "par_raw_text_t": "Do DI  6440.02 ,  May  29 ,  2014  \nChange  1 ,  05/07/2020  ", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 85, "id": "DoDI 6440.02 CH 1.pdf_85", "par_count_i": 1, "page_num": 11, "par_raw_text_t": "GLOSSARY  \n12  \nor  otherwise  describe  the  presence  or  absence  of  various  substances  or  organisms  in  the  body .   \nFacilities  only  collecting  or  preparing  specimens  ( or  both )  or  only  serving  as  a  mailing  service  \nand  not  performing  testing  are  not  considered  laboratories .", "entities": {"ORG_s": [], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}, {"type": "paragraph", "filename": "DoDI 6440.02 CH 1.pdf", "par_inc_count": 86, "id": "DoDI 6440.02 CH 1.pdf_86", "par_count_i": 2, "page_num": 11, "par_raw_text_t": "LJWG .   An  organization  that  provides  unified  leadership  to  guide  and  influence  OASD ( HA )  \npolicy  and  decision  making  on  DoD  clinical  and  anatomic  laboratory  operations .   Leads  \nstandardization  and  consolidation  efforts  across  the  DoD ;  and ,  when  or  where  appropriate ,  with  \nthe  VA  to  improve  utilization ,  quality ,  and  customer  support  while  focusing  on  cost  effective  \nbusiness  practices .", "entities": {"ORG_s": ["VA", "DoD"], "GPE_s": [], "NORP_s": [], "LAW_s": [], "LOC_s": [], "PERSON_s": []}}], "ref_list": ["DoDD 5124.02", "DoDI 6440.2", "DoDI 6440.02", "DoDM 6440.02", "Title 10", "CFR Title 42", "PL 100-578"], "top_entities_t": ["DoD", "Military Department", "DHA", "Laboratory", "ASD"], "topics_s": [], "abbreviations_n": [], "summary_30": "", "pagerank_r": 1e-05, "pop_score": 0.0, "word_count": 2803, "sections": {"all_sections": ["Department of Defense ", "INSTRUCTION ", "NUMBER 6440.02 ", "May 29, 2014 ", "Incorporating Change 1, Effective May 7, 2020 ", "USD(P&R) ", "SUBJECT: Clinical Laboratory Improvement Program (CLIP) ", "References: See Enclosure 1 ", "1. PURPOSE.  This instruction:\na. Reissues DoD Instruction (DoDI) 6440.2 (Reference (a)), in accordance with the authority\nin DoD Directive 5124.02 (Reference (b)) and pursuant to the Memorandum of Understanding between the Department of Defense and the Department of Health and Human Services (HHS) \n(Reference (c)), Public Law 100-578 (Reference (d)), and part 493 of Title 42, Code of Federal \nRegulations (Reference (e)), to establish policy, assign responsibilities, and prescribe standards and procedures to implement and administer the CLIP within the DoD. \nb. Establishes the Center for Clinical Laboratory Medicine (CCLM), formerly known as the\nClinical Laboratory Improvement Program Office, under the Defense Health Agency (DHA).  \nCCLM has the primary responsibility to develop Clinical Laboratory Improvement Amendments \n(CLIA) comparable regulations and administer the CLIP in accordance with Reference (c). ", "2. APPLICABILITY.  This instruction applies to the OSD, the Military Departments, the Office\nof the Chairman of the Joint Chiefs of Staff and the Joint Staff, the Combatant Commands, the\nOffice of the Inspector General of the Department of Defense, the Defense Agencies, the DoD\nField Activities, and all other organizational entities within the DoD (referred to collectively in\nthis instruction as the \u201cDoD Components\u201d).", "3. POLICY\na. In accordance with Reference (c), CLIA comparable regulations will incorporate, to the\nmaximum extent possible, the regulations issued by HHS pursuant to Reference (e).  These may be modified only as may be required to meet unique aspects of DoD missions, training, and preparations during peace, contingency, and wartime operations which precludes exact compliance with CLIA. \nb. In accordance with this instruction and Reference (c), the DoD will ensure the quality and\nreliability of laboratory testing at facilities conducting testing on materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings. ", "4. RESPONSIBILITIES.  See Enclosure 2.", "5. PROCEDURES.  See Enclosure 3.", "6. RELEASABILITY.  Cleared for public release.  This instruction is available on the\nDirectives Division Website at https://www.esd.whs.mil/DD/.", "7. SUMMARY OF CHANGE 1.  The change to this issuance updates references and removes\nexpiration language in accordance with current Chief Management Officer of the Department of\nDefense direction.", "8. EFFECTIVE DATE.  This instruction is effective May 29, 2014.", "Enclosures \n1. References\n2. Responsibilities\n3. Procedures\nGlossary ", "CONTENTS ", "TABLE OF CONTENTS \nENCLOSURE 1:  REFERENCES ...................................................................................................4 \nENCLOSURE 2:  RESPONSIBILITIES .........................................................................................5 \nASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS (ASD(HA)) ..............5 \nDIRECTOR, DHA .....................................................................................................................5 \nSECRETARIES OF THE MILITARY DEPARTMENTS........................................................5 \nENCLOSURE 3:  PROCEDURES ..................................................................................................7 \nDHA ...........................................................................................................................................7 \nCCLM  .......................................................................................................................................7 \nMILITARY DEPARTMENTS ..................................................................................................8 \nGLOSSARY ..................................................................................................................................11 \nPART I:  ABBREVIATIONS AND ACRONYMS ................................................................11 \nPART II:  DEFINITIONS ........................................................................................................11 ", "ENCLOSURE 1 REFERENCES \n(a)\nDoD Instruction 6440.2, \u201cDoD Clinical Laboratory Improvement Program,\u201d April 20, 1994\n(hereby cancelled)\n(b)\nDoD Directive 5124.02, \u201cUnder Secretary of Defense for Personnel and Readiness\n(USD(P&R)),\u201d June 23, 2008\n(c)\nMemorandum of Understanding between the Department of Defense and the Department of\nHealth and Human Services on the Clinical Laboratory Improvement Amendments of 1988\n(CLIA 1988), January 14, 2009\n(d)\nPublic Law 100-578, \u201cClinical Laboratory Improvement Amendments of 1988,\u201d\nOctober 31, 1988\n(e)\nPart 493 of Title 42, Code of Federal Regulations\n(f)\nChapter 55 of Title 10, United States Code\n(g)\nDoD Manual 6440.02, \u201cClinical Laboratory Improvement Program (CLIP) Manual,\u201d\nMay 29, 2014", "ENCLOSURE 2 RESPONSIBILITIES \n1. ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS (ASD(HA)).  Under\nthe authority, direction, and control of the Under Secretary of Defense for Personnel and\nReadiness, the ASD(HA):\na. Establishes DoD procedures and supporting guidance.  Exercises authority, oversight, and\nresponsibility for implementation of CLIA-comparable regulations within DoD pursuant to \nReference (c) and in accordance with References (d) and (e), and Chapter 55 of Title 10, United \nStates Code (Reference (f)). \nb. Establishes the CCLM in the DHA.\n2. DIRECTOR, DHA. Under the authority, direction, and control of the ASD(HA):\na. Executes those responsibilities and functions pertaining to the day-to-day operations of the\nCCLM and CLIP as described in Enclosure 3 of this instruction. \nb. Appoints the Director, CCLM.  This position should rotate among the three O-6-level\nCCLM Military Department Directors. \n2. SECRETARIES OF THE MILITARY DEPARTMENTS.  The Secretaries of the Military\nDepartments:\na. Implement CLIP requirements within their respective Department\u2019s Active and Reserve\nComponents and facilities under their supervision to include oversight, inspections, proficiency testing, personnel standards, and training in laboratories performing testing on human specimens as defined under \u201claboratory\u201d in the Glossary of this instruction. \nb. In accordance with DoD Manual 6440.02 (Reference (g)), follow CLIP procedures for corrective action on laboratory facilities whose proficiency testing or performance criteria fall outside the standards of CLIP policy. \nc. In accordance with Reference (g), implement the standards and procedures governing the operation, management, and oversight of clinical laboratory assets assigned to operational forces.  \nExcept where operational constraints preclude compliance, the standards governing clinical laboratory assets assigned to operational forces will incorporate the CLIP policy to the maximum extent possible without impeding operational requirements. \nd. Recommend changes and revisions to CLIP standards to CCLM.\nENCLOSURE 2 \ne.  Oversee Surgeon General, laboratory commander, and laboratory medical director implementation of the procedures in Enclosure 3 of this instruction.  ", "ENCLOSURE 3 PROCEDURES \n1.  DHA.  The DHA:   \na.  Provides administrative and operational management and support to CCLM, including the budget, personnel, information, facilities, and other resources required to support the missions and function of the CCLM.  The Director, DHA, at least annually reports CCLM activities to the \nAssistant Secretary of Defense for Health Affairs (ASD(HA)). \nb.  The Director, DHA, secures adequate funding for the CCLM.  Funding will be within the \nDefense Health Program (DHP), incorporated with the Military Health System DHP submission during the Budget Estimation Submission, President\u2019s Budget, and Program Objective \nMemorandum. \n2.  CCLM.  The Director, CCLM:  \na.  Plans, organizes, and leads the technical and management operations of CCLM and applies resources to short-term and long-term goals.  Coordinates complex and future administration and business strategy programs with DoD senior leaders and headquarters staff.  \nInteracts with the Joint Staff, other government agencies and laboratory customers of the \nMilitary Departments driving programmatic and budgetary initiatives.   \nb.  Coordinates the day-to-day activities of the CCLM, in accordance with the policies established by the OASD(HA), and the plans, programs, standards, and procedures established by the DoD and the Military Departments. \nc.  Develops and establishes the minimum standards and procedures, and CLIA comparable regulations to be used by the Military Departments to implement References (b), (c), and (d). \nd.  Serves as the primary laboratory representative with Centers for Medicare & Medicaid \nServices (CMS), Food and Drug Administration (FDA), and other federal and civilian agencies. \ne.  Working in coordination with the DoD-Department of Veterans Affairs (VA) Laboratory \nJoint Working Group (LJWG), provides unified leadership to guide and influence OASD(HA) \npolicy and decision making on DoD clinical and anatomic pathology operations. \nf.  Leads standardization and consolidation efforts across the DoD, and when or where appropriate, with the VA; to improve utilization, quality, and customer support while focusing on cost effective business practices.  These coordinated efforts may include, but are not limited to, the following: \nENCLOSURE 3 \n(1)  Establish inter-Service networks and referral lab services to coordinate, recapture, and direct implementation of standardized or consolidated military laboratory services or initiatives in the most cost-effective manner. \n(2)  Identify and make recommendations to the Military Departments concerning duplicative services to ensure cost-effective utilization of laboratory resources in the direct-care and purchased-care sectors. \n(3)  Develop processes and structures guiding laboratory medicine related decisions and policies as appropriate. \n(4)  Collaborate with the Military Departments to develop DoD laboratory medicine costing, funding, and manning mechanisms as appropriate. \n(5)  Research and recommend clinical and anatomic laboratory information management systems, recommend advances to and implement state-of-the-art technology, and establish full system interoperability for laboratory data transfer. \n(6)  Coordinate inter-Service efforts for equipment standardization and contract management. \n(7)  Working in coordination with the Executive Secretary of the DoD Laboratory \nNetwork (DLN), and within the governance rules of the DLN, will:  Establish, support, and expand, as appropriate for bio-defense, the continental United States and outside the continental \nUnited States Laboratory Response Network in conjunction with the Centers for Disease \nControl, FDA, VA, and other federal agencies. \n(8)  Establish, support, and expand test systems and processes, as appropriate, for readiness and force health protection in both in-garrison medical treatment facilities and in deployed military treatment facilities. \n3.  MILITARY DEPARTMENTS \na.  The Surgeons General of the Military Departments: \n(1)  Appoint laboratory officers in the grade of O-6 to serve as clinical laboratory consultant or specialty leader to their respective Surgeon General and as their Military \nDepartment\u2019s Director at CCLM.  The same individual may serve in both capacities for a \nMilitary Department. \n(2)  Assign three medical laboratory technicians (one from each Department - Air Force, Army, and Navy) in the grade of E-7 or above, serving as CLIP program managers for their respective Military Department.  All CCLM members carry out CCLM assignments as their primary duty.  These are priority fill positions and require an interview by the respective CCLM \nMilitary Department Director. \nENCLOSURE 3 \n(3)  Assign additional staff to include:  one Air Force Biomedical Laboratory Officer, in the grade of O-4 serving as the Deputy Director, CCLM; one Army Clinical Laboratory Officer in the grade 0-3/0-4, possessing an advanced Information Technology degree to serve as the \nLaboratory Informatics Program Manager; one Navy Advanced Laboratory Technician in the grade of E-5 or above serving as the Assistant Program Manager of CLIP.  These are priority fill positions and require an interview by the respective CCLM Military Department Director. \nb.  Commanders of laboratories performing testing on materials derived from the human body for the purpose of diagnosis or treatment will ensure compliance with CLIA comparable regulations as defined by CCLM and ensure CLIP registration of all medical laboratories within their command as applicable. \nc.  Laboratory medical directors have primary oversight and responsibility for ensuring compliance with all regulations and guidance described in References (b), (c), and (d) and other applicable accrediting agency requirements and CCLM standards and procedures. \nd.  The Military Department Directors, CCLM: \n(1)  Provide executive oversight of the CLIP program for their respective Military \nDepartment.  Monitor regulatory and statutory changes to public law and recommend appropriate changes to DoD standards.  Maintain contact with regulatory organizations or other agencies for the provision of inspection, accreditation, and proficiency testing services required for DoD laboratories. \n(2)  Monitor proficiency testing and accreditation agency inspection results, and overall \nCLIP compliance for their respective service laboratories.  When deemed necessary, initiate or recommend enforcement procedures.  Review and validate corrective action plans.  Provide information on performance or deficiencies to the respective Surgeons General when action is required for resolution.   \n(3)  Issue laboratory certification documents, and certify all appropriate clinical laboratory testing sites within the DoD. \n(4)  As the OASD(HA) designee: \n(a)  Impose sanctions or other corrective actions deemed appropriate for CLIP \ncertified laboratories with repetitive failures of CMS-approved proficiency failures or other non-compliance with CLIP policy and CLIA comparable regulations as defined by CCLM.   \n(b)  Revoke the CLIP certification of laboratories whose actions significantly endanger patient care. \n(c)  Reinstate the CLIP certification for laboratories that have successfully completed corrective actions.  \nENCLOSURE 3 \n(5)  Interact with their respective Military Department\u2019s Surgeon General on matters relating to References (c), (d), (e), and (f). \n(6)  Provide to the ASD(HA), Director DHA and Military Department Surgeons General, a listing of clinical laboratories of the DoD Components to which suspension, limitation, or revocation of CLIP certificates have been imposed. \n(7)  Provide information on clinical laboratory issues and regulatory compliance to registered sites via newsletters, seminars, and workshops as appropriate.  Respond to regulatory and accreditation compliance questions from registered sites. \n(8)  Provide consultation and impact analysis for laboratory policy issues for the \nASD(HA), Director DHA and Military Department Surgeons General. \n(9)  Prepare reports for laboratory consulting activities for the ASD(HA), Director DHA \nand Military Department Surgeons General. \n(10)  Respond to complaints relative to laboratory services from federal, State, or DoD beneficiaries and provides consultation or inspection of sites where appropriate. \n(11)  Assist the Director, CCLM, with the duties outlined in paragraphs 2a through 2f of this enclosure. \ne.  CLIP Program Managers and Assistant Program Managers: \n(1)  Serve as primary liaison for their respective Military Department\u2019s laboratories on matters pertaining to the CLIP.  \n(2)  In accordance with Reference (d), assist in executive oversight of the CLIP program for their respective Military Department.  Maintain contact with regulatory organizations or other agencies for the provision of inspection, accreditation, and proficiency testing services required for DoD laboratories. \n(3)  Monitor proficiency testing and accreditation agency inspection results and overall \nCLIP compliance for their respective service laboratories.  When necessary, initiate or recommend enforcement procedures.  Review and validate corrective action plans.  Provide information on performance or deficiencies to the respective Military Department\u2019s Director or the CCLM Deputy Director when action is required for resolution. \n(4)  Prepare laboratory certification documents for all appropriate clinical laboratory testing sites within their Military Department. \n(5)  Maintain CLIP database and prepare reports of laboratory activities for their respective Military Department\u2019s Director, or the CCLM Deputy Director. ", "GLOSSARY \nPART I.  ABBREVIATIONS AND ACRONYMS \nASD(HA) \nAssistant Secretary of Defense for Health Affairs \nCCLM \nCenter for Clinical Laboratory Medicine \nCLIA \nClinical Laboratory Improvement Amendments of 1988 \nCLIP \nClinical Laboratory Improvement Program \nCMS \nCenters for Medicare & Medicaid Services \nDHA \nDefense Health Agency \nDHP \nDefense Health Program \nDLN \nDoD Laboratory Network \nDoDI \nDoD instruction \nFDA \nFood and Drug Administration \nHHS \nDepartment of Health and Human Services \nLJWG \nLaboratory Joint Working Group \nOASD(HA) Office of the Assistant Secretary of Defense for Health Affairs \nVA \nDepartment of Veterans Affairs \nPART II.  DEFINITIONS \nThese terms and their definitions are for the purposes of this instruction. \nCLIA comparable regulations.  Regulations and instructions for the DoD Components based on the CLIA regulations issued by the HHS.  CLIA comparable regulations are similar to, but not necessarily identical to, HHS CLIA regulations, modified only as may be required to meet unique aspects of DoD missions, training, and preparations during peace, contingency, and wartime operations which preclude compliance with CLIA. \nCLIP.  Body of rules and regulations establishing the minimum standards for clinical laboratory operations within the DoD, developed by CCLM, with the approval of OASD(HA), and implemented by DoD Components. \nlaboratory.  A facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings.  These examinations also include procedures to determine, measure, GLOSSARY \nor otherwise describe the presence or absence of various substances or organisms in the body.  \nFacilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered laboratories. \nLJWG.  An organization that provides unified leadership to guide and influence OASD(HA) \npolicy and decision making on DoD clinical and anatomic laboratory operations.  Leads standardization and consolidation efforts across the DoD; and, when or where appropriate, with the VA to improve utilization, quality, and customer support while focusing on cost effective business practices. "], "responsibilities_section": ["4. RESPONSIBILITIES.  See Enclosure 2.", "ENCLOSURE 2 RESPONSIBILITIES \n1. ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS (ASD(HA)).  Under\nthe authority, direction, and control of the Under Secretary of Defense for Personnel and\nReadiness, the ASD(HA):\na. Establishes DoD procedures and supporting guidance.  Exercises authority, oversight, and\nresponsibility for implementation of CLIA-comparable regulations within DoD pursuant to \nReference (c) and in accordance with References (d) and (e), and Chapter 55 of Title 10, United \nStates Code (Reference (f)). \nb. Establishes the CCLM in the DHA.\n2. DIRECTOR, DHA. Under the authority, direction, and control of the ASD(HA):\na. Executes those responsibilities and functions pertaining to the day-to-day operations of the\nCCLM and CLIP as described in Enclosure 3 of this instruction. \nb. Appoints the Director, CCLM.  This position should rotate among the three O-6-level\nCCLM Military Department Directors. \n2. SECRETARIES OF THE MILITARY DEPARTMENTS.  The Secretaries of the Military\nDepartments:\na. Implement CLIP requirements within their respective Department\u2019s Active and Reserve\nComponents and facilities under their supervision to include oversight, inspections, proficiency testing, personnel standards, and training in laboratories performing testing on human specimens as defined under \u201claboratory\u201d in the Glossary of this instruction. \nb. In accordance with DoD Manual 6440.02 (Reference (g)), follow CLIP procedures for corrective action on laboratory facilities whose proficiency testing or performance criteria fall outside the standards of CLIP policy. \nc. In accordance with Reference (g), implement the standards and procedures governing the operation, management, and oversight of clinical laboratory assets assigned to operational forces.  \nExcept where operational constraints preclude compliance, the standards governing clinical laboratory assets assigned to operational forces will incorporate the CLIP policy to the maximum extent possible without impeding operational requirements. \nd. Recommend changes and revisions to CLIP standards to CCLM.\nENCLOSURE 2 \ne.  Oversee Surgeon General, laboratory commander, and laboratory medical director implementation of the procedures in Enclosure 3 of this instruction.  "], "references_section": ["References: See Enclosure 1 ", "ENCLOSURE 1 REFERENCES \n(a)\nDoD Instruction 6440.2, \u201cDoD Clinical Laboratory Improvement Program,\u201d April 20, 1994\n(hereby cancelled)\n(b)\nDoD Directive 5124.02, \u201cUnder Secretary of Defense for Personnel and Readiness\n(USD(P&R)),\u201d June 23, 2008\n(c)\nMemorandum of Understanding between the Department of Defense and the Department of\nHealth and Human Services on the Clinical Laboratory Improvement Amendments of 1988\n(CLIA 1988), January 14, 2009\n(d)\nPublic Law 100-578, \u201cClinical Laboratory Improvement Amendments of 1988,\u201d\nOctober 31, 1988\n(e)\nPart 493 of Title 42, Code of Federal Regulations\n(f)\nChapter 55 of Title 10, United States Code\n(g)\nDoD Manual 6440.02, \u201cClinical Laboratory Improvement Program (CLIP) Manual,\u201d\nMay 29, 2014"], "purpose_section": ["1. PURPOSE.  This instruction:\na. Reissues DoD Instruction (DoDI) 6440.2 (Reference (a)), in accordance with the authority\nin DoD Directive 5124.02 (Reference (b)) and pursuant to the Memorandum of Understanding between the Department of Defense and the Department of Health and Human Services (HHS) \n(Reference (c)), Public Law 100-578 (Reference (d)), and part 493 of Title 42, Code of Federal \nRegulations (Reference (e)), to establish policy, assign responsibilities, and prescribe standards and procedures to implement and administer the CLIP within the DoD. \nb. Establishes the Center for Clinical Laboratory Medicine (CCLM), formerly known as the\nClinical Laboratory Improvement Program Office, under the Defense Health Agency (DHA).  \nCCLM has the primary responsibility to develop Clinical Laboratory Improvement Amendments \n(CLIA) comparable regulations and administer the CLIP in accordance with Reference (c). "], "subject_section": ["SUBJECT: Clinical Laboratory Improvement Program (CLIP) "], "procedures_section": ["5. PROCEDURES.  See Enclosure 3.", "ENCLOSURE 3 PROCEDURES \n1.  DHA.  The DHA:   \na.  Provides administrative and operational management and support to CCLM, including the budget, personnel, information, facilities, and other resources required to support the missions and function of the CCLM.  The Director, DHA, at least annually reports CCLM activities to the \nAssistant Secretary of Defense for Health Affairs (ASD(HA)). \nb.  The Director, DHA, secures adequate funding for the CCLM.  Funding will be within the \nDefense Health Program (DHP), incorporated with the Military Health System DHP submission during the Budget Estimation Submission, President\u2019s Budget, and Program Objective \nMemorandum. \n2.  CCLM.  The Director, CCLM:  \na.  Plans, organizes, and leads the technical and management operations of CCLM and applies resources to short-term and long-term goals.  Coordinates complex and future administration and business strategy programs with DoD senior leaders and headquarters staff.  \nInteracts with the Joint Staff, other government agencies and laboratory customers of the \nMilitary Departments driving programmatic and budgetary initiatives.   \nb.  Coordinates the day-to-day activities of the CCLM, in accordance with the policies established by the OASD(HA), and the plans, programs, standards, and procedures established by the DoD and the Military Departments. \nc.  Develops and establishes the minimum standards and procedures, and CLIA comparable regulations to be used by the Military Departments to implement References (b), (c), and (d). \nd.  Serves as the primary laboratory representative with Centers for Medicare & Medicaid \nServices (CMS), Food and Drug Administration (FDA), and other federal and civilian agencies. \ne.  Working in coordination with the DoD-Department of Veterans Affairs (VA) Laboratory \nJoint Working Group (LJWG), provides unified leadership to guide and influence OASD(HA) \npolicy and decision making on DoD clinical and anatomic pathology operations. \nf.  Leads standardization and consolidation efforts across the DoD, and when or where appropriate, with the VA; to improve utilization, quality, and customer support while focusing on cost effective business practices.  These coordinated efforts may include, but are not limited to, the following: \nENCLOSURE 3 \n(1)  Establish inter-Service networks and referral lab services to coordinate, recapture, and direct implementation of standardized or consolidated military laboratory services or initiatives in the most cost-effective manner. \n(2)  Identify and make recommendations to the Military Departments concerning duplicative services to ensure cost-effective utilization of laboratory resources in the direct-care and purchased-care sectors. \n(3)  Develop processes and structures guiding laboratory medicine related decisions and policies as appropriate. \n(4)  Collaborate with the Military Departments to develop DoD laboratory medicine costing, funding, and manning mechanisms as appropriate. \n(5)  Research and recommend clinical and anatomic laboratory information management systems, recommend advances to and implement state-of-the-art technology, and establish full system interoperability for laboratory data transfer. \n(6)  Coordinate inter-Service efforts for equipment standardization and contract management. \n(7)  Working in coordination with the Executive Secretary of the DoD Laboratory \nNetwork (DLN), and within the governance rules of the DLN, will:  Establish, support, and expand, as appropriate for bio-defense, the continental United States and outside the continental \nUnited States Laboratory Response Network in conjunction with the Centers for Disease \nControl, FDA, VA, and other federal agencies. \n(8)  Establish, support, and expand test systems and processes, as appropriate, for readiness and force health protection in both in-garrison medical treatment facilities and in deployed military treatment facilities. \n3.  MILITARY DEPARTMENTS \na.  The Surgeons General of the Military Departments: \n(1)  Appoint laboratory officers in the grade of O-6 to serve as clinical laboratory consultant or specialty leader to their respective Surgeon General and as their Military \nDepartment\u2019s Director at CCLM.  The same individual may serve in both capacities for a \nMilitary Department. \n(2)  Assign three medical laboratory technicians (one from each Department - Air Force, Army, and Navy) in the grade of E-7 or above, serving as CLIP program managers for their respective Military Department.  All CCLM members carry out CCLM assignments as their primary duty.  These are priority fill positions and require an interview by the respective CCLM \nMilitary Department Director. \nENCLOSURE 3 \n(3)  Assign additional staff to include:  one Air Force Biomedical Laboratory Officer, in the grade of O-4 serving as the Deputy Director, CCLM; one Army Clinical Laboratory Officer in the grade 0-3/0-4, possessing an advanced Information Technology degree to serve as the \nLaboratory Informatics Program Manager; one Navy Advanced Laboratory Technician in the grade of E-5 or above serving as the Assistant Program Manager of CLIP.  These are priority fill positions and require an interview by the respective CCLM Military Department Director. \nb.  Commanders of laboratories performing testing on materials derived from the human body for the purpose of diagnosis or treatment will ensure compliance with CLIA comparable regulations as defined by CCLM and ensure CLIP registration of all medical laboratories within their command as applicable. \nc.  Laboratory medical directors have primary oversight and responsibility for ensuring compliance with all regulations and guidance described in References (b), (c), and (d) and other applicable accrediting agency requirements and CCLM standards and procedures. \nd.  The Military Department Directors, CCLM: \n(1)  Provide executive oversight of the CLIP program for their respective Military \nDepartment.  Monitor regulatory and statutory changes to public law and recommend appropriate changes to DoD standards.  Maintain contact with regulatory organizations or other agencies for the provision of inspection, accreditation, and proficiency testing services required for DoD laboratories. \n(2)  Monitor proficiency testing and accreditation agency inspection results, and overall \nCLIP compliance for their respective service laboratories.  When deemed necessary, initiate or recommend enforcement procedures.  Review and validate corrective action plans.  Provide information on performance or deficiencies to the respective Surgeons General when action is required for resolution.   \n(3)  Issue laboratory certification documents, and certify all appropriate clinical laboratory testing sites within the DoD. \n(4)  As the OASD(HA) designee: \n(a)  Impose sanctions or other corrective actions deemed appropriate for CLIP \ncertified laboratories with repetitive failures of CMS-approved proficiency failures or other non-compliance with CLIP policy and CLIA comparable regulations as defined by CCLM.   \n(b)  Revoke the CLIP certification of laboratories whose actions significantly endanger patient care. \n(c)  Reinstate the CLIP certification for laboratories that have successfully completed corrective actions.  \nENCLOSURE 3 \n(5)  Interact with their respective Military Department\u2019s Surgeon General on matters relating to References (c), (d), (e), and (f). \n(6)  Provide to the ASD(HA), Director DHA and Military Department Surgeons General, a listing of clinical laboratories of the DoD Components to which suspension, limitation, or revocation of CLIP certificates have been imposed. \n(7)  Provide information on clinical laboratory issues and regulatory compliance to registered sites via newsletters, seminars, and workshops as appropriate.  Respond to regulatory and accreditation compliance questions from registered sites. \n(8)  Provide consultation and impact analysis for laboratory policy issues for the \nASD(HA), Director DHA and Military Department Surgeons General. \n(9)  Prepare reports for laboratory consulting activities for the ASD(HA), Director DHA \nand Military Department Surgeons General. \n(10)  Respond to complaints relative to laboratory services from federal, State, or DoD beneficiaries and provides consultation or inspection of sites where appropriate. \n(11)  Assist the Director, CCLM, with the duties outlined in paragraphs 2a through 2f of this enclosure. \ne.  CLIP Program Managers and Assistant Program Managers: \n(1)  Serve as primary liaison for their respective Military Department\u2019s laboratories on matters pertaining to the CLIP.  \n(2)  In accordance with Reference (d), assist in executive oversight of the CLIP program for their respective Military Department.  Maintain contact with regulatory organizations or other agencies for the provision of inspection, accreditation, and proficiency testing services required for DoD laboratories. \n(3)  Monitor proficiency testing and accreditation agency inspection results and overall \nCLIP compliance for their respective service laboratories.  When necessary, initiate or recommend enforcement procedures.  Review and validate corrective action plans.  Provide information on performance or deficiencies to the respective Military Department\u2019s Director or the CCLM Deputy Director when action is required for resolution. \n(4)  Prepare laboratory certification documents for all appropriate clinical laboratory testing sites within their Military Department. \n(5)  Maintain CLIP database and prepare reports of laboratory activities for their respective Military Department\u2019s Director, or the CCLM Deputy Director. "], "effective_date_section": ["8. EFFECTIVE DATE.  This instruction is effective May 29, 2014."], "applicability_section": [["2. APPLICABILITY.  This instruction applies to the OSD, the Military Departments, the Office", "of the Chairman of the Joint Chiefs of Staff and the Joint Staff, the Combatant Commands, the", "Office of the Inspector General of the Department of Defense, the Defense Agencies, the DoD", "Field Activities, and all other organizational entities within the DoD (referred to collectively in", "this instruction as the \u201cDoD Components\u201d)."]], "policy_section": ["3. POLICY\na. In accordance with Reference (c), CLIA comparable regulations will incorporate, to the\nmaximum extent possible, the regulations issued by HHS pursuant to Reference (e).  These may be modified only as may be required to meet unique aspects of DoD missions, training, and preparations during peace, contingency, and wartime operations which precludes exact compliance with CLIA. \nb. In accordance with this instruction and Reference (c), the DoD will ensure the quality and\nreliability of laboratory testing at facilities conducting testing on materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings. "], "organizations_section": [], "definitions_section": [], "table_of_contents": ["TABLE OF CONTENTS \nENCLOSURE 1:  REFERENCES ...................................................................................................4 \nENCLOSURE 2:  RESPONSIBILITIES .........................................................................................5 \nASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS (ASD(HA)) ..............5 \nDIRECTOR, DHA .....................................................................................................................5 \nSECRETARIES OF THE MILITARY DEPARTMENTS........................................................5 \nENCLOSURE 3:  PROCEDURES ..................................................................................................7 \nDHA ...........................................................................................................................................7 \nCCLM  .......................................................................................................................................7 \nMILITARY DEPARTMENTS ..................................................................................................8 \nGLOSSARY ..................................................................................................................................11 \nPART I:  ABBREVIATIONS AND ACRONYMS ................................................................11 \nPART II:  DEFINITIONS ........................................................................................................11 "], "glossary_section": ["GLOSSARY \nPART I.  ABBREVIATIONS AND ACRONYMS \nASD(HA) \nAssistant Secretary of Defense for Health Affairs \nCCLM \nCenter for Clinical Laboratory Medicine \nCLIA \nClinical Laboratory Improvement Amendments of 1988 \nCLIP \nClinical Laboratory Improvement Program \nCMS \nCenters for Medicare & Medicaid Services \nDHA \nDefense Health Agency \nDHP \nDefense Health Program \nDLN \nDoD Laboratory Network \nDoDI \nDoD instruction \nFDA \nFood and Drug Administration \nHHS \nDepartment of Health and Human Services \nLJWG \nLaboratory Joint Working Group \nOASD(HA) Office of the Assistant Secretary of Defense for Health Affairs \nVA \nDepartment of Veterans Affairs \nPART II.  DEFINITIONS \nThese terms and their definitions are for the purposes of this instruction. \nCLIA comparable regulations.  Regulations and instructions for the DoD Components based on the CLIA regulations issued by the HHS.  CLIA comparable regulations are similar to, but not necessarily identical to, HHS CLIA regulations, modified only as may be required to meet unique aspects of DoD missions, training, and preparations during peace, contingency, and wartime operations which preclude compliance with CLIA. \nCLIP.  Body of rules and regulations establishing the minimum standards for clinical laboratory operations within the DoD, developed by CCLM, with the approval of OASD(HA), and implemented by DoD Components. \nlaboratory.  A facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings.  These examinations also include procedures to determine, measure, GLOSSARY \nor otherwise describe the presence or absence of various substances or organisms in the body.  \nFacilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered laboratories. \nLJWG.  An organization that provides unified leadership to guide and influence OASD(HA) \npolicy and decision making on DoD clinical and anatomic laboratory operations.  Leads standardization and consolidation efforts across the DoD; and, when or where appropriate, with the VA to improve utilization, quality, and customer support while focusing on cost effective business practices. "], "summary_of_change_section": ["7. SUMMARY OF CHANGE 1.  The change to this issuance updates references and removes\nexpiration language in accordance with current Chief Management Officer of the Department of\nDefense direction."]}, "raw_text": "Department of Defense \nINSTRUCTION \nNUMBER 6440.02 \nMay 29, 2014 \nIncorporating Change 1, Effective May 7, 2020 \nUSD(P&R) \nSUBJECT: Clinical Laboratory Improvement Program (CLIP) \nReferences: See Enclosure 1 \n1. PURPOSE.  This instruction:\na. Reissues DoD Instruction (DoDI) 6440.2 (Reference (a)), in accordance with the authority\nin DoD Directive 5124.02 (Reference (b)) and pursuant to the Memorandum of Understanding \nbetween the Department of Defense and the Department of Health and Human Services (HHS) \n(Reference (c)), Public Law 100-578 (Reference (d)), and part 493 of Title 42, Code of Federal \nRegulations (Reference (e)), to establish policy, assign responsibilities, and prescribe standards \nand procedures to implement and administer the CLIP within the DoD. \nb. Establishes the Center for Clinical Laboratory Medicine (CCLM), formerly known as the\nClinical Laboratory Improvement Program Office, under the Defense Health Agency (DHA).  \nCCLM has the primary responsibility to develop Clinical Laboratory Improvement Amendments \n(CLIA) comparable regulations and administer the CLIP in accordance with Reference (c). \n2. APPLICABILITY.  This instruction applies to the OSD, the Military Departments, the Office\nof the Chairman of the Joint Chiefs of Staff and the Joint Staff, the Combatant Commands, the\nOffice of the Inspector General of the Department of Defense, the Defense Agencies, the DoD\nField Activities, and all other organizational entities within the DoD (referred to collectively in\nthis instruction as the \u201cDoD Components\u201d).\n3. POLICY\na. In accordance with Reference (c), CLIA comparable regulations will incorporate, to the\nmaximum extent possible, the regulations issued by HHS pursuant to Reference (e).  These may \nbe modified only as may be required to meet unique aspects of DoD missions, training, and \npreparations during peace, contingency, and wartime operations which precludes exact \ncompliance with CLIA. \nDoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n2 \nb. In accordance with this instruction and Reference (c), the DoD will ensure the quality and\nreliability of laboratory testing at facilities conducting testing on materials derived from the \nhuman body for the purpose of providing information for the diagnosis, prevention, or treatment \nof any disease or impairment of, or the assessment of the health of, human beings. \n4. RESPONSIBILITIES.  See Enclosure 2.\n5. PROCEDURES.  See Enclosure 3.\n6. RELEASABILITY.  Cleared for public release.  This instruction is available on the\nDirectives Division Website at https://www.esd.whs.mil/DD/.\n7. SUMMARY OF CHANGE 1.  The change to this issuance updates references and removes\nexpiration language in accordance with current Chief Management Officer of the Department of\nDefense direction.\n8. EFFECTIVE DATE.  This instruction is effective May 29, 2014.\nEnclosures \n1. References\n2. Responsibilities\n3. Procedures\nGlossary \nDoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nCONTENTS \n3 \nTABLE OF CONTENTS \nENCLOSURE 1:  REFERENCES ...................................................................................................4 \nENCLOSURE 2:  RESPONSIBILITIES .........................................................................................5 \nASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS (ASD(HA)) ..............5 \nDIRECTOR, DHA .....................................................................................................................5 \nSECRETARIES OF THE MILITARY DEPARTMENTS........................................................5 \nENCLOSURE 3:  PROCEDURES ..................................................................................................7 \nDHA ...........................................................................................................................................7 \nCCLM  .......................................................................................................................................7 \nMILITARY DEPARTMENTS ..................................................................................................8 \nGLOSSARY ..................................................................................................................................11 \nPART I:  ABBREVIATIONS AND ACRONYMS ................................................................11 \nPART II:  DEFINITIONS ........................................................................................................11 \nDoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 1 \n4 \nENCLOSURE 1 \nREFERENCES \n(a)\nDoD Instruction 6440.2, \u201cDoD Clinical Laboratory Improvement Program,\u201d April 20, 1994\n(hereby cancelled)\n(b)\nDoD Directive 5124.02, \u201cUnder Secretary of Defense for Personnel and Readiness\n(USD(P&R)),\u201d June 23, 2008\n(c)\nMemorandum of Understanding between the Department of Defense and the Department of\nHealth and Human Services on the Clinical Laboratory Improvement Amendments of 1988\n(CLIA 1988), January 14, 2009\n(d)\nPublic Law 100-578, \u201cClinical Laboratory Improvement Amendments of 1988,\u201d\nOctober 31, 1988\n(e)\nPart 493 of Title 42, Code of Federal Regulations\n(f)\nChapter 55 of Title 10, United States Code\n(g)\nDoD Manual 6440.02, \u201cClinical Laboratory Improvement Program (CLIP) Manual,\u201d\nMay 29, 2014\nDoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 2 \n5 \nENCLOSURE 2 \nRESPONSIBILITIES \n1. ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS (ASD(HA)).  Under\nthe authority, direction, and control of the Under Secretary of Defense for Personnel and\nReadiness, the ASD(HA):\na. Establishes DoD procedures and supporting guidance.  Exercises authority, oversight, and\nresponsibility for implementation of CLIA-comparable regulations within DoD pursuant to \nReference (c) and in accordance with References (d) and (e), and Chapter 55 of Title 10, United \nStates Code (Reference (f)). \nb. Establishes the CCLM in the DHA.\n2. DIRECTOR, DHA. Under the authority, direction, and control of the ASD(HA):\na. Executes those responsibilities and functions pertaining to the day-to-day operations of the\nCCLM and CLIP as described in Enclosure 3 of this instruction. \nb. Appoints the Director, CCLM.  This position should rotate among the three O-6-level\nCCLM Military Department Directors. \n2. SECRETARIES OF THE MILITARY DEPARTMENTS.  The Secretaries of the Military\nDepartments:\na. Implement CLIP requirements within their respective Department\u2019s Active and Reserve\nComponents and facilities under their supervision to include oversight, inspections, proficiency \ntesting, personnel standards, and training in laboratories performing testing on human specimens \nas defined under \u201claboratory\u201d in the Glossary of this instruction. \nb. In accordance with DoD Manual 6440.02 (Reference (g)), follow CLIP procedures for \ncorrective action on laboratory facilities whose proficiency testing or performance criteria fall \noutside the standards of CLIP policy. \nc. In accordance with Reference (g), implement the standards and procedures governing the \noperation, management, and oversight of clinical laboratory assets assigned to operational forces.  \nExcept where operational constraints preclude compliance, the standards governing clinical \nlaboratory assets assigned to operational forces will incorporate the CLIP policy to the maximum \nextent possible without impeding operational requirements. \nd. Recommend changes and revisions to CLIP standards to CCLM.\nDoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 2 \n \n6 \ne.  Oversee Surgeon General, laboratory commander, and laboratory medical director \nimplementation of the procedures in Enclosure 3 of this instruction.  \nDoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 3 \n7 \nENCLOSURE 3 \n \nPROCEDURES \n \n \n1.  DHA.  The DHA:   \n \n \na.  Provides administrative and operational management and support to CCLM, including the \nbudget, personnel, information, facilities, and other resources required to support the missions \nand function of the CCLM.  The Director, DHA, at least annually reports CCLM activities to the \nAssistant Secretary of Defense for Health Affairs (ASD(HA)). \n \n \nb.  The Director, DHA, secures adequate funding for the CCLM.  Funding will be within the \nDefense Health Program (DHP), incorporated with the Military Health System DHP submission \nduring the Budget Estimation Submission, President\u2019s Budget, and Program Objective \nMemorandum. \n \n \n2.  CCLM.  The Director, CCLM:  \n \na.  Plans, organizes, and leads the technical and management operations of CCLM and \napplies resources to short-term and long-term goals.  Coordinates complex and future \nadministration and business strategy programs with DoD senior leaders and headquarters staff.  \nInteracts with the Joint Staff, other government agencies and laboratory customers of the \nMilitary Departments driving programmatic and budgetary initiatives.   \n \nb.  Coordinates the day-to-day activities of the CCLM, in accordance with the policies \nestablished by the OASD(HA), and the plans, programs, standards, and procedures established \nby the DoD and the Military Departments. \n \nc.  Develops and establishes the minimum standards and procedures, and CLIA comparable \nregulations to be used by the Military Departments to implement References (b), (c), and (d). \n \nd.  Serves as the primary laboratory representative with Centers for Medicare & Medicaid \nServices (CMS), Food and Drug Administration (FDA), and other federal and civilian agencies. \n \ne.  Working in coordination with the DoD-Department of Veterans Affairs (VA) Laboratory \nJoint Working Group (LJWG), provides unified leadership to guide and influence OASD(HA) \npolicy and decision making on DoD clinical and anatomic pathology operations. \n \nf.  Leads standardization and consolidation efforts across the DoD, and when or where \nappropriate, with the VA; to improve utilization, quality, and customer support while focusing on \ncost effective business practices.  These coordinated efforts may include, but are not limited to, \nthe following: \n \nDoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 3 \n8 \n \n \n(1)  Establish inter-Service networks and referral lab services to coordinate, recapture, \nand direct implementation of standardized or consolidated military laboratory services or \ninitiatives in the most cost-effective manner. \n \n \n \n(2)  Identify and make recommendations to the Military Departments concerning \nduplicative services to ensure cost-effective utilization of laboratory resources in the direct-care \nand purchased-care sectors. \n \n \n \n(3)  Develop processes and structures guiding laboratory medicine related decisions and \npolicies as appropriate. \n \n \n \n(4)  Collaborate with the Military Departments to develop DoD laboratory medicine \ncosting, funding, and manning mechanisms as appropriate. \n \n \n \n(5)  Research and recommend clinical and anatomic laboratory information management \nsystems, recommend advances to and implement state-of-the-art technology, and establish full \nsystem interoperability for laboratory data transfer. \n \n \n \n(6)  Coordinate inter-Service efforts for equipment standardization and contract \nmanagement. \n \n \n \n(7)  Working in coordination with the Executive Secretary of the DoD Laboratory \nNetwork (DLN), and within the governance rules of the DLN, will:  Establish, support, and \nexpand, as appropriate for bio-defense, the continental United States and outside the continental \nUnited States Laboratory Response Network in conjunction with the Centers for Disease \nControl, FDA, VA, and other federal agencies. \n \n \n \n(8)  Establish, support, and expand test systems and processes, as appropriate, for \nreadiness and force health protection in both in-garrison medical treatment facilities and in \ndeployed military treatment facilities. \n \n \n3.  MILITARY DEPARTMENTS \n \na.  The Surgeons General of the Military Departments: \n \n \n(1)  Appoint laboratory officers in the grade of O-6 to serve as clinical laboratory \nconsultant or specialty leader to their respective Surgeon General and as their Military \nDepartment\u2019s Director at CCLM.  The same individual may serve in both capacities for a \nMilitary Department. \n \n \n \n(2)  Assign three medical laboratory technicians (one from each Department - Air Force, \nArmy, and Navy) in the grade of E-7 or above, serving as CLIP program managers for their \nrespective Military Department.  All CCLM members carry out CCLM assignments as their \nprimary duty.  These are priority fill positions and require an interview by the respective CCLM \nMilitary Department Director. \nDoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 3 \n9 \n \n \n \n(3)  Assign additional staff to include:  one Air Force Biomedical Laboratory Officer, in \nthe grade of O-4 serving as the Deputy Director, CCLM; one Army Clinical Laboratory Officer \nin the grade 0-3/0-4, possessing an advanced Information Technology degree to serve as the \nLaboratory Informatics Program Manager; one Navy Advanced Laboratory Technician in the \ngrade of E-5 or above serving as the Assistant Program Manager of CLIP.  These are priority fill \npositions and require an interview by the respective CCLM Military Department Director. \n \nb.  Commanders of laboratories performing testing on materials derived from the human \nbody for the purpose of diagnosis or treatment will ensure compliance with CLIA comparable \nregulations as defined by CCLM and ensure CLIP registration of all medical laboratories within \ntheir command as applicable. \n \nc.  Laboratory medical directors have primary oversight and responsibility for ensuring \ncompliance with all regulations and guidance described in References (b), (c), and (d) and other \napplicable accrediting agency requirements and CCLM standards and procedures. \n \nd.  The Military Department Directors, CCLM: \n \n(1)  Provide executive oversight of the CLIP program for their respective Military \nDepartment.  Monitor regulatory and statutory changes to public law and recommend appropriate \nchanges to DoD standards.  Maintain contact with regulatory organizations or other agencies for \nthe provision of inspection, accreditation, and proficiency testing services required for DoD \nlaboratories. \n \n(2)  Monitor proficiency testing and accreditation agency inspection results, and overall \nCLIP compliance for their respective service laboratories.  When deemed necessary, initiate or \nrecommend enforcement procedures.  Review and validate corrective action plans.  Provide \ninformation on performance or deficiencies to the respective Surgeons General when action is \nrequired for resolution.   \n \n(3)  Issue laboratory certification documents, and certify all appropriate clinical \nlaboratory testing sites within the DoD. \n \n(4)  As the OASD(HA) designee: \n \n(a)  Impose sanctions or other corrective actions deemed appropriate for CLIP \ncertified laboratories with repetitive failures of CMS-approved proficiency failures or other non-\ncompliance with CLIP policy and CLIA comparable regulations as defined by CCLM.   \n \n(b)  Revoke the CLIP certification of laboratories whose actions significantly \nendanger patient care. \n \n(c)  Reinstate the CLIP certification for laboratories that have successfully completed \ncorrective actions.  \n \nDoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nENCLOSURE 3 \n10 \n(5)  Interact with their respective Military Department\u2019s Surgeon General on matters \nrelating to References (c), (d), (e), and (f). \n \n(6)  Provide to the ASD(HA), Director DHA and Military Department Surgeons General, \na listing of clinical laboratories of the DoD Components to which suspension, limitation, or \nrevocation of CLIP certificates have been imposed. \n \n(7)  Provide information on clinical laboratory issues and regulatory compliance to \nregistered sites via newsletters, seminars, and workshops as appropriate.  Respond to regulatory \nand accreditation compliance questions from registered sites. \n \n(8)  Provide consultation and impact analysis for laboratory policy issues for the \nASD(HA), Director DHA and Military Department Surgeons General. \n \n(9)  Prepare reports for laboratory consulting activities for the ASD(HA), Director DHA \nand Military Department Surgeons General. \n \n(10)  Respond to complaints relative to laboratory services from federal, State, or DoD \nbeneficiaries and provides consultation or inspection of sites where appropriate. \n \n(11)  Assist the Director, CCLM, with the duties outlined in paragraphs 2a through 2f of \nthis enclosure. \n \ne.  CLIP Program Managers and Assistant Program Managers: \n \n(1)  Serve as primary liaison for their respective Military Department\u2019s laboratories on \nmatters pertaining to the CLIP.  \n \n(2)  In accordance with Reference (d), assist in executive oversight of the CLIP program \nfor their respective Military Department.  Maintain contact with regulatory organizations or other \nagencies for the provision of inspection, accreditation, and proficiency testing services required \nfor DoD laboratories. \n \n(3)  Monitor proficiency testing and accreditation agency inspection results and overall \nCLIP compliance for their respective service laboratories.  When necessary, initiate or \nrecommend enforcement procedures.  Review and validate corrective action plans.  Provide \ninformation on performance or deficiencies to the respective Military Department\u2019s Director or \nthe CCLM Deputy Director when action is required for resolution. \n \n(4)  Prepare laboratory certification documents for all appropriate clinical laboratory \ntesting sites within their Military Department. \n \n(5)  Maintain CLIP database and prepare reports of laboratory activities for their \nrespective Military Department\u2019s Director, or the CCLM Deputy Director. \n \n \nDoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nGLOSSARY \n11 \nGLOSSARY \n \nPART I.  ABBREVIATIONS AND ACRONYMS \n \nASD(HA) \nAssistant Secretary of Defense for Health Affairs \n \n \nCCLM \nCenter for Clinical Laboratory Medicine \nCLIA \nClinical Laboratory Improvement Amendments of 1988 \nCLIP \nClinical Laboratory Improvement Program \nCMS \nCenters for Medicare & Medicaid Services \n \nDHA \nDefense Health Agency \nDHP \nDefense Health Program \nDLN \nDoD Laboratory Network \nDoDI \nDoD instruction \n \n \nFDA \nFood and Drug Administration \n \n \nHHS \nDepartment of Health and Human Services \n \n \nLJWG \nLaboratory Joint Working Group \n \n \nOASD(HA) Office of the Assistant Secretary of Defense for Health Affairs \n \n \nVA \nDepartment of Veterans Affairs \n \n \nPART II.  DEFINITIONS \n \nThese terms and their definitions are for the purposes of this instruction. \n \nCLIA comparable regulations.  Regulations and instructions for the DoD Components based on \nthe CLIA regulations issued by the HHS.  CLIA comparable regulations are similar to, but not \nnecessarily identical to, HHS CLIA regulations, modified only as may be required to meet \nunique aspects of DoD missions, training, and preparations during peace, contingency, and \nwartime operations which preclude compliance with CLIA. \n \nCLIP.  Body of rules and regulations establishing the minimum standards for clinical laboratory \noperations within the DoD, developed by CCLM, with the approval of OASD(HA), and \nimplemented by DoD Components. \n \nlaboratory.  A facility for the biological, microbiological, serological, chemical, \nimmunohematological, hematological, biophysical, cytological, pathological, or other \nexamination of materials derived from the human body for the purpose of providing information \nfor the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of \nthe health of, human beings.  These examinations also include procedures to determine, measure, \nDoDI 6440.02, May 29, 2014 \nChange 1, 05/07/2020 \n \nGLOSSARY \n12 \nor otherwise describe the presence or absence of various substances or organisms in the body.  \nFacilities only collecting or preparing specimens (or both) or only serving as a mailing service \nand not performing testing are not considered laboratories. \n \nLJWG.  An organization that provides unified leadership to guide and influence OASD(HA) \npolicy and decision making on DoD clinical and anatomic laboratory operations.  Leads \nstandardization and consolidation efforts across the DoD; and, when or where appropriate, with \nthe VA to improve utilization, quality, and customer support while focusing on cost effective \nbusiness practices. \n", "access_timestamp_dt": "2021-08-28T13:30:53", "publication_date_dt": "2014-05-29T00:00:00", "file_ext_s": "pdf", "display_doc_type_s": "Instruction", "display_title_s": "DoDI 6440.02 Clinical Laboratory Improvement Program (CLIP)", "display_org_s": "Dept. of Defense", "data_source_s": "WHS DoD Directives Division", "source_title_s": "WHS DoD Directives", "display_source_s": "WHS DoD Directives Division - WHS DoD Directives", "is_revoked_b": false, "crawler_used_s": "dod_issuances", "source_fqdn_s": "www.esd.whs.mil", "source_page_url_s": "https://www.esd.whs.mil/Directives/issuances/dodi/", "cac_login_required_b": false, "download_url_s": "https://www.esd.whs.mil/Portals/54/Documents/DD/issuances/dodi/644002p.pdf", "version_hash_s": "50e40c3f68a4476a99fc447063eb5decb5533b9c74f42030490ca18baf3609ea"}